id	sid	tid	token	lemma	pos
cord-256217-fnjer0e0	1	1	key	key	JJ
cord-256217-fnjer0e0	2	1	:	:	:
cord-256217-fnjer0e0	2	2	cord-256217-fnjer0e0	cord-256217-fnjer0e0	DT
cord-256217-fnjer0e0	2	3	authors	author	NNS
cord-256217-fnjer0e0	2	4	:	:	:
cord-256217-fnjer0e0	2	5	Neri	Neri	NNP
cord-256217-fnjer0e0	2	6	,	,	,
cord-256217-fnjer0e0	2	7	Piergiorgio	Piergiorgio	NNP
cord-256217-fnjer0e0	2	8	;	;	:
cord-256217-fnjer0e0	2	9	Pichi	Pichi	NNP
cord-256217-fnjer0e0	2	10	,	,	,
cord-256217-fnjer0e0	2	11	Francesco	Francesco	NNP
cord-256217-fnjer0e0	2	12	title	title	NN
cord-256217-fnjer0e0	2	13	:	:	:
cord-256217-fnjer0e0	2	14	COVID-19	covid-19	VB
cord-256217-fnjer0e0	2	15	and	and	CC
cord-256217-fnjer0e0	2	16	the	the	DT
cord-256217-fnjer0e0	2	17	eye	eye	NN
cord-256217-fnjer0e0	2	18	immunity	immunity	NN
cord-256217-fnjer0e0	2	19	:	:	:
cord-256217-fnjer0e0	2	20	lesson	lesson	NN
cord-256217-fnjer0e0	2	21	learned	learn	VBN
cord-256217-fnjer0e0	2	22	from	from	IN
cord-256217-fnjer0e0	2	23	the	the	DT
cord-256217-fnjer0e0	2	24	past	past	NN
cord-256217-fnjer0e0	2	25	and	and	CC
cord-256217-fnjer0e0	2	26	possible	possible	JJ
cord-256217-fnjer0e0	2	27	new	new	JJ
cord-256217-fnjer0e0	2	28	therapeutic	therapeutic	JJ
cord-256217-fnjer0e0	2	29	insights	insight	NNS
cord-256217-fnjer0e0	2	30	date	date	NN
cord-256217-fnjer0e0	2	31	:	:	:
cord-256217-fnjer0e0	2	32	2020	2020	CD
cord-256217-fnjer0e0	2	33	-	-	HYPH
cord-256217-fnjer0e0	2	34	04	04	CD
cord-256217-fnjer0e0	2	35	-	-	SYM
cord-256217-fnjer0e0	2	36	20	20	CD
cord-256217-fnjer0e0	2	37	journal	journal	NN
cord-256217-fnjer0e0	2	38	:	:	:
cord-256217-fnjer0e0	3	1	Int	Int	NNP
cord-256217-fnjer0e0	3	2	Ophthalmol	Ophthalmol	NNP
cord-256217-fnjer0e0	3	3	DOI	DOI	NNP
cord-256217-fnjer0e0	3	4	:	:	:
cord-256217-fnjer0e0	3	5	10.1007	10.1007	CD
cord-256217-fnjer0e0	3	6	/	/	SYM
cord-256217-fnjer0e0	3	7	s10792	s10792	NN
cord-256217-fnjer0e0	3	8	-	-	HYPH
cord-256217-fnjer0e0	3	9	020	020	CD
cord-256217-fnjer0e0	4	1	-01389	-01389	:
cord-256217-fnjer0e0	4	2	-	-	:
cord-256217-fnjer0e0	4	3	2	2	CD
cord-256217-fnjer0e0	4	4	sha	sha	NN
cord-256217-fnjer0e0	4	5	:	:	:
cord-256217-fnjer0e0	4	6	5bc55e0dd200e698ef6bb147e4945b7fabde6428	5bc55e0dd200e698ef6bb147e4945b7fabde6428	CD
cord-256217-fnjer0e0	4	7	doc_id	doc_id	CD
cord-256217-fnjer0e0	4	8	:	:	:
cord-256217-fnjer0e0	4	9	256217	256217	CD
cord-256217-fnjer0e0	4	10	cord_uid	cord_uid	NNS
cord-256217-fnjer0e0	4	11	:	:	:
cord-256217-fnjer0e0	5	1	fnjer0e0	fnjer0e0	NNP
cord-256217-fnjer0e0	5	2	nan	nan	NNP
cord-256217-fnjer0e0	5	3	Corona	Corona	NNP
cord-256217-fnjer0e0	5	4	virus	virus	NN
cord-256217-fnjer0e0	5	5	represents	represent	VBZ
cord-256217-fnjer0e0	5	6	nowadays	nowadays	RB
cord-256217-fnjer0e0	5	7	the	the	DT
cord-256217-fnjer0e0	5	8	hot	hot	JJ
cord-256217-fnjer0e0	5	9	topic	topic	NN
cord-256217-fnjer0e0	5	10	in	in	IN
cord-256217-fnjer0e0	5	11	the	the	DT
cord-256217-fnjer0e0	5	12	scientific	scientific	JJ
cord-256217-fnjer0e0	5	13	world	world	NN
cord-256217-fnjer0e0	5	14	due	due	IN
cord-256217-fnjer0e0	5	15	to	to	IN
cord-256217-fnjer0e0	5	16	the	the	DT
cord-256217-fnjer0e0	5	17	outbreak	outbreak	NN
cord-256217-fnjer0e0	5	18	of	of	IN
cord-256217-fnjer0e0	5	19	a	a	DT
cord-256217-fnjer0e0	5	20	novel	novel	JJ
cord-256217-fnjer0e0	5	21	serotype	serotype	NN
cord-256217-fnjer0e0	5	22	formerly	formerly	RB
cord-256217-fnjer0e0	5	23	named	name	VBN
cord-256217-fnjer0e0	5	24	coronavirus	coronavirus	NN
cord-256217-fnjer0e0	5	25	disease	disease	NN
cord-256217-fnjer0e0	5	26	(	(	-LRB-
cord-256217-fnjer0e0	5	27	COVID)-19	covid)-19	JJ
cord-256217-fnjer0e0	5	28	and	and	CC
cord-256217-fnjer0e0	5	29	now	now	RB
cord-256217-fnjer0e0	5	30	identified	identify	VBN
cord-256217-fnjer0e0	5	31	as	as	IN
cord-256217-fnjer0e0	5	32	severe	severe	JJ
cord-256217-fnjer0e0	5	33	acute	acute	JJ
cord-256217-fnjer0e0	5	34	respiratory	respiratory	JJ
cord-256217-fnjer0e0	5	35	syndrome	syndrome	NN
cord-256217-fnjer0e0	5	36	(	(	-LRB-
cord-256217-fnjer0e0	5	37	SARS)-COV-2	sars)-cov-2	JJ
cord-256217-fnjer0e0	5	38	[	[	-LRB-
cord-256217-fnjer0e0	5	39	1	1	CD
cord-256217-fnjer0e0	5	40	]	]	-RRB-
cord-256217-fnjer0e0	5	41	.	.	.
cord-256217-fnjer0e0	6	1	The	the	DT
cord-256217-fnjer0e0	6	2	disease	disease	NN
cord-256217-fnjer0e0	6	3	has	have	VBZ
cord-256217-fnjer0e0	6	4	been	be	VBN
cord-256217-fnjer0e0	6	5	firstly	firstly	RB
cord-256217-fnjer0e0	6	6	reported	report	VBN
cord-256217-fnjer0e0	6	7	in	in	IN
cord-256217-fnjer0e0	6	8	Wuhan	Wuhan	NNP
cord-256217-fnjer0e0	6	9	,	,	,
cord-256217-fnjer0e0	6	10	Yubei	Yubei	NNP
cord-256217-fnjer0e0	6	11	District	District	NNP
cord-256217-fnjer0e0	6	12	of	of	IN
cord-256217-fnjer0e0	6	13	the	the	DT
cord-256217-fnjer0e0	6	14	Republic	Republic	NNP
cord-256217-fnjer0e0	6	15	of	of	IN
cord-256217-fnjer0e0	6	16	China	China	NNP
cord-256217-fnjer0e0	6	17	,	,	,
cord-256217-fnjer0e0	6	18	when	when	WRB
cord-256217-fnjer0e0	6	19	in	in	IN
cord-256217-fnjer0e0	6	20	December	December	NNP
cord-256217-fnjer0e0	6	21	2019	2019	CD
cord-256217-fnjer0e0	6	22	its	-PRON-	PRP$
cord-256217-fnjer0e0	6	23	outbreak	outbreak	NN
cord-256217-fnjer0e0	6	24	affected	affect	VBN
cord-256217-fnjer0e0	6	25	around	around	IN
cord-256217-fnjer0e0	6	26	80,000	80,000	CD
cord-256217-fnjer0e0	6	27	people	people	NNS
cord-256217-fnjer0e0	6	28	and	and	CC
cord-256217-fnjer0e0	6	29	provoked	provoke	VBD
cord-256217-fnjer0e0	6	30	about	about	IN
cord-256217-fnjer0e0	6	31	3000	3000	CD
cord-256217-fnjer0e0	6	32	deaths	death	NNS
cord-256217-fnjer0e0	6	33	due	due	JJ
cord-256217-fnjer0e0	6	34	to	to	IN
cord-256217-fnjer0e0	6	35	pulmonary	pulmonary	JJ
cord-256217-fnjer0e0	6	36	complications	complication	NNS
cord-256217-fnjer0e0	6	37	[	[	-LRB-
cord-256217-fnjer0e0	6	38	1	1	CD
cord-256217-fnjer0e0	6	39	]	]	-RRB-
cord-256217-fnjer0e0	6	40	.	.	.
cord-256217-fnjer0e0	7	1	The	the	DT
cord-256217-fnjer0e0	7	2	virus	virus	NN
cord-256217-fnjer0e0	7	3	rapidly	rapidly	RB
cord-256217-fnjer0e0	7	4	spread	spread	VBD
cord-256217-fnjer0e0	7	5	all	all	RB
cord-256217-fnjer0e0	7	6	over	over	IN
cord-256217-fnjer0e0	7	7	the	the	DT
cord-256217-fnjer0e0	7	8	world	world	NN
cord-256217-fnjer0e0	7	9	and	and	CC
cord-256217-fnjer0e0	7	10	was	be	VBD
cord-256217-fnjer0e0	7	11	recognized	recognize	VBN
cord-256217-fnjer0e0	7	12	as	as	IN
cord-256217-fnjer0e0	7	13	a	a	DT
cord-256217-fnjer0e0	7	14	pandemic	pandemic	NN
cord-256217-fnjer0e0	7	15	by	by	IN
cord-256217-fnjer0e0	7	16	the	the	DT
cord-256217-fnjer0e0	7	17	World	World	NNP
cord-256217-fnjer0e0	7	18	Health	Health	NNP
cord-256217-fnjer0e0	7	19	Organization	Organization	NNP
cord-256217-fnjer0e0	7	20	(	(	-LRB-
cord-256217-fnjer0e0	7	21	WHO	who	WP
cord-256217-fnjer0e0	7	22	)	)	-RRB-
cord-256217-fnjer0e0	7	23	on	on	IN
cord-256217-fnjer0e0	7	24	March	March	NNP
cord-256217-fnjer0e0	7	25	11	11	CD
cord-256217-fnjer0e0	7	26	,	,	,
cord-256217-fnjer0e0	7	27	2020	2020	CD
cord-256217-fnjer0e0	7	28	[	[	-LRB-
cord-256217-fnjer0e0	7	29	2	2	CD
cord-256217-fnjer0e0	7	30	]	]	-RRB-
cord-256217-fnjer0e0	7	31	.	.	.
cord-256217-fnjer0e0	8	1	In	in	IN
cord-256217-fnjer0e0	8	2	4	4	CD
cord-256217-fnjer0e0	8	3	months	month	NNS
cord-256217-fnjer0e0	8	4	,	,	,
cord-256217-fnjer0e0	8	5	the	the	DT
cord-256217-fnjer0e0	8	6	disease	disease	NN
cord-256217-fnjer0e0	8	7	was	be	VBD
cord-256217-fnjer0e0	8	8	recognized	recognize	VBN
cord-256217-fnjer0e0	8	9	in	in	IN
cord-256217-fnjer0e0	8	10	about	about	RB
cord-256217-fnjer0e0	8	11	1,521,252	1,521,252	CD
cord-256217-fnjer0e0	8	12	people	people	NNS
cord-256217-fnjer0e0	8	13	and	and	CC
cord-256217-fnjer0e0	8	14	made	make	VBD
cord-256217-fnjer0e0	8	15	92,798	92,798	CD
cord-256217-fnjer0e0	8	16	victims	victim	NNS
cord-256217-fnjer0e0	8	17	mainly	mainly	RB
cord-256217-fnjer0e0	8	18	in	in	IN
cord-256217-fnjer0e0	8	19	elderly	elderly	JJ
cord-256217-fnjer0e0	8	20	and	and	CC
cord-256217-fnjer0e0	8	21	compromised	compromised	JJ
cord-256217-fnjer0e0	8	22	patients	patient	NNS
cord-256217-fnjer0e0	8	23	.	.	.
cord-256217-fnjer0e0	9	1	On	on	IN
cord-256217-fnjer0e0	9	2	an	an	DT
cord-256217-fnjer0e0	9	3	official	official	JJ
cord-256217-fnjer0e0	9	4	report	report	NN
cord-256217-fnjer0e0	9	5	released	release	VBN
cord-256217-fnjer0e0	9	6	on	on	IN
cord-256217-fnjer0e0	9	7	April	April	NNP
cord-256217-fnjer0e0	9	8	10	10	CD
cord-256217-fnjer0e0	9	9	,	,	,
cord-256217-fnjer0e0	9	10	2020	2020	CD
cord-256217-fnjer0e0	9	11	,	,	,
cord-256217-fnjer0e0	9	12	SARS	SARS	NNP
cord-256217-fnjer0e0	9	13	-	-	HYPH
cord-256217-fnjer0e0	9	14	COV-2	COV-2	NNP
cord-256217-fnjer0e0	9	15	carried	carry	VBD
cord-256217-fnjer0e0	9	16	a	a	DT
cord-256217-fnjer0e0	9	17	mortality	mortality	NN
cord-256217-fnjer0e0	9	18	rate	rate	NN
cord-256217-fnjer0e0	9	19	around	around	IN
cord-256217-fnjer0e0	9	20	6.1	6.1	CD
cord-256217-fnjer0e0	9	21	%	%	NN
cord-256217-fnjer0e0	9	22	compared	compare	VBN
cord-256217-fnjer0e0	9	23	to	to	IN
cord-256217-fnjer0e0	9	24	influenza	influenza	NN
cord-256217-fnjer0e0	9	25	that	that	WDT
cord-256217-fnjer0e0	9	26	is	be	VBZ
cord-256217-fnjer0e0	9	27	supposed	suppose	VBN
cord-256217-fnjer0e0	9	28	be	be	VB
cord-256217-fnjer0e0	9	29	around	around	IN
cord-256217-fnjer0e0	9	30	1	1	CD
cord-256217-fnjer0e0	9	31	%	%	NN
cord-256217-fnjer0e0	9	32	[	[	-LRB-
cord-256217-fnjer0e0	9	33	3	3	CD
cord-256217-fnjer0e0	9	34	]	]	-RRB-
cord-256217-fnjer0e0	9	35	.	.	.
cord-256217-fnjer0e0	10	1	All	all	DT
cord-256217-fnjer0e0	10	2	countries	country	NNS
cord-256217-fnjer0e0	10	3	are	be	VBP
cord-256217-fnjer0e0	10	4	encountering	encounter	VBG
cord-256217-fnjer0e0	10	5	massive	massive	JJ
cord-256217-fnjer0e0	10	6	and	and	CC
cord-256217-fnjer0e0	10	7	dramatic	dramatic	JJ
cord-256217-fnjer0e0	10	8	problems	problem	NNS
cord-256217-fnjer0e0	10	9	in	in	IN
cord-256217-fnjer0e0	10	10	terms	term	NNS
cord-256217-fnjer0e0	10	11	of	of	IN
cord-256217-fnjer0e0	10	12	prevention	prevention	NN
cord-256217-fnjer0e0	10	13	and	and	CC
cord-256217-fnjer0e0	10	14	sustainability	sustainability	NN
cord-256217-fnjer0e0	10	15	of	of	IN
cord-256217-fnjer0e0	10	16	treatments	treatment	NNS
cord-256217-fnjer0e0	10	17	for	for	IN
cord-256217-fnjer0e0	10	18	this	this	DT
cord-256217-fnjer0e0	10	19	disease	disease	NN
cord-256217-fnjer0e0	10	20	which	which	WDT
cord-256217-fnjer0e0	10	21	does	do	VBZ
cord-256217-fnjer0e0	10	22	not	not	RB
cord-256217-fnjer0e0	10	23	have	have	VB
cord-256217-fnjer0e0	10	24	a	a	DT
cord-256217-fnjer0e0	10	25	universally	universally	RB
cord-256217-fnjer0e0	10	26	agreed	agree	VBN
cord-256217-fnjer0e0	10	27	therapeutic	therapeutic	JJ
cord-256217-fnjer0e0	10	28	protocol	protocol	NN
cord-256217-fnjer0e0	10	29	.	.	.
cord-256217-fnjer0e0	11	1	Current	current	JJ
cord-256217-fnjer0e0	11	2	management	management	NN
cord-256217-fnjer0e0	11	3	of	of	IN
cord-256217-fnjer0e0	11	4	COVID-19	COVID-19	NNP
cord-256217-fnjer0e0	11	5	is	be	VBZ
cord-256217-fnjer0e0	11	6	mainly	mainly	RB
cord-256217-fnjer0e0	11	7	supportive	supportive	JJ
cord-256217-fnjer0e0	11	8	,	,	,
cord-256217-fnjer0e0	11	9	even	even	RB
cord-256217-fnjer0e0	11	10	though	though	IN
cord-256217-fnjer0e0	11	11	the	the	DT
cord-256217-fnjer0e0	11	12	medical	medical	JJ
cord-256217-fnjer0e0	11	13	literature	literature	NN
cord-256217-fnjer0e0	11	14	has	have	VBZ
cord-256217-fnjer0e0	11	15	reported	report	VBN
cord-256217-fnjer0e0	11	16	several	several	JJ
cord-256217-fnjer0e0	11	17	rescue	rescue	NN
cord-256217-fnjer0e0	11	18	strategies	strategy	NNS
cord-256217-fnjer0e0	11	19	which	which	WDT
cord-256217-fnjer0e0	11	20	might	may	MD
cord-256217-fnjer0e0	11	21	minimize	minimize	VB
cord-256217-fnjer0e0	11	22	the	the	DT
cord-256217-fnjer0e0	11	23	mortality	mortality	NN
cord-256217-fnjer0e0	11	24	rate	rate	NN
cord-256217-fnjer0e0	11	25	in	in	IN
cord-256217-fnjer0e0	11	26	those	those	DT
cord-256217-fnjer0e0	11	27	who	who	WP
cord-256217-fnjer0e0	11	28	have	have	VBP
cord-256217-fnjer0e0	11	29	severe	severe	JJ
cord-256217-fnjer0e0	11	30	pulmonary	pulmonary	JJ
cord-256217-fnjer0e0	11	31	complications	complication	NNS
cord-256217-fnjer0e0	11	32	.	.	.
cord-256217-fnjer0e0	12	1	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-256217-fnjer0e0	12	2	and	and	CC
cord-256217-fnjer0e0	12	3	azithromycin	azithromycin	NNP
cord-256217-fnjer0e0	12	4	combination	combination	NN
cord-256217-fnjer0e0	12	5	seems	seem	VBZ
cord-256217-fnjer0e0	12	6	to	to	TO
cord-256217-fnjer0e0	12	7	be	be	VB
cord-256217-fnjer0e0	12	8	a	a	DT
cord-256217-fnjer0e0	12	9	valid	valid	JJ
cord-256217-fnjer0e0	12	10	possible	possible	JJ
cord-256217-fnjer0e0	12	11	therapeutic	therapeutic	JJ
cord-256217-fnjer0e0	12	12	protocol	protocol	NN
cord-256217-fnjer0e0	12	13	[	[	-LRB-
cord-256217-fnjer0e0	12	14	4	4	CD
cord-256217-fnjer0e0	12	15	]	]	-RRB-
cord-256217-fnjer0e0	12	16	and	and	CC
cord-256217-fnjer0e0	12	17	is	be	VBZ
cord-256217-fnjer0e0	12	18	currently	currently	RB
cord-256217-fnjer0e0	12	19	under	under	IN
cord-256217-fnjer0e0	12	20	urgent	urgent	JJ
cord-256217-fnjer0e0	12	21	investigation	investigation	NN
cord-256217-fnjer0e0	12	22	.	.	.
cord-256217-fnjer0e0	13	1	Unfortunately	unfortunately	RB
cord-256217-fnjer0e0	13	2	,	,	,
cord-256217-fnjer0e0	13	3	the	the	DT
cord-256217-fnjer0e0	13	4	real	real	JJ
cord-256217-fnjer0e0	13	5	challenge	challenge	NN
cord-256217-fnjer0e0	13	6	is	be	VBZ
cord-256217-fnjer0e0	13	7	represented	represent	VBN
cord-256217-fnjer0e0	13	8	by	by	IN
cord-256217-fnjer0e0	13	9	those	those	DT
cord-256217-fnjer0e0	13	10	cases	case	NNS
cord-256217-fnjer0e0	13	11	where	where	WRB
cord-256217-fnjer0e0	13	12	the	the	DT
cord-256217-fnjer0e0	13	13	severe	severe	JJ
cord-256217-fnjer0e0	13	14	form	form	NN
cord-256217-fnjer0e0	13	15	of	of	IN
cord-256217-fnjer0e0	13	16	SARS	SARS	NNP
cord-256217-fnjer0e0	13	17	-	-	HYPH
cord-256217-fnjer0e0	13	18	COV-2	COV-2	NNP
cord-256217-fnjer0e0	13	19	interstitial	interstitial	JJ
cord-256217-fnjer0e0	13	20	pneumonia	pneumonia	NN
cord-256217-fnjer0e0	13	21	occurs	occur	VBZ
cord-256217-fnjer0e0	13	22	,	,	,
cord-256217-fnjer0e0	13	23	with	with	IN
cord-256217-fnjer0e0	13	24	acute	acute	JJ
cord-256217-fnjer0e0	13	25	respiratory	respiratory	JJ
cord-256217-fnjer0e0	13	26	distress	distress	NN
cord-256217-fnjer0e0	13	27	syndrome	syndrome	NN
cord-256217-fnjer0e0	13	28	(	(	-LRB-
cord-256217-fnjer0e0	13	29	ARDS	ARDS	NNP
cord-256217-fnjer0e0	13	30	)	)	-RRB-
cord-256217-fnjer0e0	13	31	that	that	WDT
cord-256217-fnjer0e0	13	32	might	may	MD
cord-256217-fnjer0e0	13	33	lead	lead	VB
cord-256217-fnjer0e0	13	34	to	to	IN
cord-256217-fnjer0e0	13	35	fatal	fatal	JJ
cord-256217-fnjer0e0	13	36	events	event	NNS
cord-256217-fnjer0e0	13	37	[	[	-LRB-
cord-256217-fnjer0e0	13	38	5	5	CD
cord-256217-fnjer0e0	13	39	]	]	-RRB-
cord-256217-fnjer0e0	13	40	.	.	.
cord-256217-fnjer0e0	14	1	The	the	DT
cord-256217-fnjer0e0	14	2	urgent	urgent	JJ
cord-256217-fnjer0e0	14	3	need	need	NN
cord-256217-fnjer0e0	14	4	to	to	TO
cord-256217-fnjer0e0	14	5	find	find	VB
cord-256217-fnjer0e0	14	6	a	a	DT
cord-256217-fnjer0e0	14	7	treatment	treatment	NN
cord-256217-fnjer0e0	14	8	for	for	IN
cord-256217-fnjer0e0	14	9	such	such	JJ
cord-256217-fnjer0e0	14	10	lifethreatening	lifethreatening	JJ
cord-256217-fnjer0e0	14	11	condition	condition	NN
cord-256217-fnjer0e0	14	12	has	have	VBZ
cord-256217-fnjer0e0	14	13	led	lead	VBN
cord-256217-fnjer0e0	14	14	to	to	IN
cord-256217-fnjer0e0	14	15	off	off	IN
cord-256217-fnjer0e0	14	16	-	-	HYPH
cord-256217-fnjer0e0	14	17	label	label	NN
cord-256217-fnjer0e0	14	18	approaches	approach	NNS
cord-256217-fnjer0e0	14	19	based	base	VBN
cord-256217-fnjer0e0	14	20	on	on	IN
cord-256217-fnjer0e0	14	21	the	the	DT
cord-256217-fnjer0e0	14	22	possible	possible	JJ
cord-256217-fnjer0e0	14	23	hypercytokinemia	hypercytokinemia	NN
cord-256217-fnjer0e0	14	24	with	with	IN
cord-256217-fnjer0e0	14	25	multiorgan	multiorgan	NNP
cord-256217-fnjer0e0	14	26	failure	failure	NN
cord-256217-fnjer0e0	14	27	[	[	-LRB-
cord-256217-fnjer0e0	14	28	6	6	CD
cord-256217-fnjer0e0	14	29	]	]	-RRB-
cord-256217-fnjer0e0	14	30	.	.	.
cord-256217-fnjer0e0	15	1	An	an	DT
cord-256217-fnjer0e0	15	2	experimental	experimental	JJ
cord-256217-fnjer0e0	15	3	protocol	protocol	NN
cord-256217-fnjer0e0	15	4	using	use	VBG
cord-256217-fnjer0e0	15	5	an	an	DT
cord-256217-fnjer0e0	15	6	anti	anti	JJ
cord-256217-fnjer0e0	15	7	-	-	JJ
cord-256217-fnjer0e0	15	8	interleukin	interleukin	JJ
cord-256217-fnjer0e0	15	9	(	(	-LRB-
cord-256217-fnjer0e0	15	10	IL)-6	IL)-6	NNP
cord-256217-fnjer0e0	15	11	receptor	receptor	NN
cord-256217-fnjer0e0	15	12	monoclonal	monoclonal	JJ
cord-256217-fnjer0e0	15	13	antibody	antibody	NN
cord-256217-fnjer0e0	15	14	named	name	VBN
cord-256217-fnjer0e0	15	15	tocilizumab	tocilizumab	NNP
cord-256217-fnjer0e0	16	1	(	(	-LRB-
cord-256217-fnjer0e0	16	2	Actemra	Actemra	NNP
cord-256217-fnjer0e0	16	3	,	,	,
cord-256217-fnjer0e0	16	4	Roche	Roche	NNP
cord-256217-fnjer0e0	16	5	Pharma	Pharma	NNP
cord-256217-fnjer0e0	16	6	(	(	-LRB-
cord-256217-fnjer0e0	16	7	Schweiz	Schweiz	NNP
cord-256217-fnjer0e0	16	8	)	)	-RRB-
cord-256217-fnjer0e0	16	9	Ltd	Ltd	NNP
cord-256217-fnjer0e0	16	10	,	,	,
cord-256217-fnjer0e0	16	11	B2084B21	B2084B21	NNP
cord-256217-fnjer0e0	16	12	)	)	-RRB-
cord-256217-fnjer0e0	16	13	has	have	VBZ
cord-256217-fnjer0e0	16	14	given	give	VBN
cord-256217-fnjer0e0	16	15	hope	hope	NN
cord-256217-fnjer0e0	16	16	of	of	IN
cord-256217-fnjer0e0	16	17	a	a	DT
cord-256217-fnjer0e0	16	18	possible	possible	JJ
cord-256217-fnjer0e0	16	19	effective	effective	JJ
cord-256217-fnjer0e0	16	20	therapy	therapy	NN
cord-256217-fnjer0e0	16	21	.	.	.
cord-256217-fnjer0e0	17	1	Tocilizumab	Tocilizumab	NNP
cord-256217-fnjer0e0	17	2	was	be	VBD
cord-256217-fnjer0e0	17	3	used	use	VBN
cord-256217-fnjer0e0	17	4	as	as	IN
cord-256217-fnjer0e0	17	5	a	a	DT
cord-256217-fnjer0e0	17	6	rescue	rescue	NN
cord-256217-fnjer0e0	17	7	treatment	treatment	NN
cord-256217-fnjer0e0	17	8	in	in	IN
cord-256217-fnjer0e0	17	9	a	a	DT
cord-256217-fnjer0e0	17	10	series	series	NN
cord-256217-fnjer0e0	17	11	of	of	IN
cord-256217-fnjer0e0	17	12	patients	patient	NNS
cord-256217-fnjer0e0	17	13	affected	affect	VBN
cord-256217-fnjer0e0	17	14	by	by	IN
cord-256217-fnjer0e0	17	15	severe	severe	JJ
cord-256217-fnjer0e0	17	16	interstitial	interstitial	JJ
cord-256217-fnjer0e0	17	17	pneumonia	pneumonia	NN
cord-256217-fnjer0e0	17	18	by	by	IN
cord-256217-fnjer0e0	17	19	Zhang	Zhang	NNP
cord-256217-fnjer0e0	17	20	et	et	NNP
cord-256217-fnjer0e0	17	21	al	al	NNP
cord-256217-fnjer0e0	17	22	.	.	.
cord-256217-fnjer0e0	18	1	[	[	-LRB-
cord-256217-fnjer0e0	18	2	7	7	CD
cord-256217-fnjer0e0	18	3	]	]	-RRB-
cord-256217-fnjer0e0	18	4	which	which	WDT
cord-256217-fnjer0e0	18	5	observed	observe	VBD
cord-256217-fnjer0e0	18	6	an	an	DT
cord-256217-fnjer0e0	18	7	evident	evident	JJ
cord-256217-fnjer0e0	18	8	improvement	improvement	NN
cord-256217-fnjer0e0	18	9	in	in	IN
cord-256217-fnjer0e0	18	10	both	both	DT
cord-256217-fnjer0e0	18	11	systemic	systemic	JJ
cord-256217-fnjer0e0	18	12	symptoms	symptom	NNS
cord-256217-fnjer0e0	18	13	and	and	CC
cord-256217-fnjer0e0	18	14	the	the	DT
cord-256217-fnjer0e0	18	15	specific	specific	JJ
cord-256217-fnjer0e0	18	16	pulmonary	pulmonary	JJ
cord-256217-fnjer0e0	18	17	impairment	impairment	NN
cord-256217-fnjer0e0	18	18	within	within	IN
cord-256217-fnjer0e0	18	19	a	a	DT
cord-256217-fnjer0e0	18	20	few	few	JJ
cord-256217-fnjer0e0	18	21	days	day	NNS
cord-256217-fnjer0e0	18	22	.	.	.
cord-256217-fnjer0e0	19	1	These	these	DT
cord-256217-fnjer0e0	19	2	interesting	interesting	JJ
cord-256217-fnjer0e0	19	3	results	result	NNS
cord-256217-fnjer0e0	19	4	were	be	VBD
cord-256217-fnjer0e0	19	5	followed	follow	VBN
cord-256217-fnjer0e0	19	6	by	by	IN
cord-256217-fnjer0e0	19	7	a	a	DT
cord-256217-fnjer0e0	19	8	series	series	NN
cord-256217-fnjer0e0	19	9	of	of	IN
cord-256217-fnjer0e0	19	10	other	other	JJ
cord-256217-fnjer0e0	19	11	publications	publication	NNS
cord-256217-fnjer0e0	19	12	speculating	speculate	VBG
cord-256217-fnjer0e0	19	13	on	on	IN
cord-256217-fnjer0e0	19	14	how	how	WRB
cord-256217-fnjer0e0	19	15	the	the	DT
cord-256217-fnjer0e0	19	16	inhibition	inhibition	NN
cord-256217-fnjer0e0	19	17	of	of	IN
cord-256217-fnjer0e0	19	18	immune	immune	JJ
cord-256217-fnjer0e0	19	19	checkpoints	checkpoint	NNS
cord-256217-fnjer0e0	19	20	might	may	MD
cord-256217-fnjer0e0	19	21	have	have	VB
cord-256217-fnjer0e0	19	22	exerted	exert	VBN
cord-256217-fnjer0e0	19	23	a	a	DT
cord-256217-fnjer0e0	19	24	possible	possible	JJ
cord-256217-fnjer0e0	19	25	good	good	JJ
cord-256217-fnjer0e0	19	26	control	control	NN
cord-256217-fnjer0e0	19	27	of	of	IN
cord-256217-fnjer0e0	19	28	the	the	DT
cord-256217-fnjer0e0	19	29	disease	disease	NN
cord-256217-fnjer0e0	19	30	.	.	.
cord-256217-fnjer0e0	20	1	On	on	IN
cord-256217-fnjer0e0	20	2	the	the	DT
cord-256217-fnjer0e0	20	3	other	other	JJ
cord-256217-fnjer0e0	20	4	hand	hand	NN
cord-256217-fnjer0e0	20	5	,	,	,
cord-256217-fnjer0e0	20	6	the	the	DT
cord-256217-fnjer0e0	20	7	severe	severe	JJ
cord-256217-fnjer0e0	20	8	contingent	contingent	JJ
cord-256217-fnjer0e0	20	9	situation	situation	NN
cord-256217-fnjer0e0	20	10	created	create	VBN
cord-256217-fnjer0e0	20	11	by	by	IN
cord-256217-fnjer0e0	20	12	the	the	DT
cord-256217-fnjer0e0	20	13	outbreak	outbreak	NN
cord-256217-fnjer0e0	20	14	of	of	IN
cord-256217-fnjer0e0	20	15	SARS	SARS	NNP
cord-256217-fnjer0e0	20	16	-	-	HYPH
cord-256217-fnjer0e0	20	17	COV-2	COV-2	NNP
cord-256217-fnjer0e0	20	18	infection	infection	NN
cord-256217-fnjer0e0	20	19	does	do	VBZ
cord-256217-fnjer0e0	20	20	not	not	RB
cord-256217-fnjer0e0	20	21	allow	allow	VB
cord-256217-fnjer0e0	20	22	to	to	TO
cord-256217-fnjer0e0	20	23	have	have	VB
cord-256217-fnjer0e0	20	24	good	good	JJ
cord-256217-fnjer0e0	20	25	models	model	NNS
cord-256217-fnjer0e0	20	26	to	to	TO
cord-256217-fnjer0e0	20	27	rely	rely	VB
cord-256217-fnjer0e0	20	28	on	on	IN
cord-256217-fnjer0e0	20	29	.	.	.
cord-256217-fnjer0e0	21	1	In	in	IN
cord-256217-fnjer0e0	21	2	the	the	DT
cord-256217-fnjer0e0	21	3	medical	medical	JJ
cord-256217-fnjer0e0	21	4	literature	literature	NN
cord-256217-fnjer0e0	21	5	,	,	,
cord-256217-fnjer0e0	21	6	SARS	SARS	NNP
cord-256217-fnjer0e0	21	7	coronavirus	coronavirus	NN
cord-256217-fnjer0e0	21	8	is	be	VBZ
cord-256217-fnjer0e0	21	9	associated	associate	VBN
cord-256217-fnjer0e0	21	10	with	with	IN
cord-256217-fnjer0e0	21	11	the	the	DT
cord-256217-fnjer0e0	21	12	occurrence	occurrence	NN
cord-256217-fnjer0e0	21	13	of	of	IN
cord-256217-fnjer0e0	21	14	hemophagocytic	hemophagocytic	JJ
cord-256217-fnjer0e0	21	15	lymphohistiocytosis	lymphohistiocytosis	NNP
cord-256217-fnjer0e0	21	16	(	(	-LRB-
cord-256217-fnjer0e0	21	17	sHLH	sHLH	NNP
cord-256217-fnjer0e0	21	18	)	)	-RRB-
cord-256217-fnjer0e0	21	19	which	which	WDT
cord-256217-fnjer0e0	21	20	represents	represent	VBZ
cord-256217-fnjer0e0	21	21	a	a	DT
cord-256217-fnjer0e0	21	22	lifethreatening	lifethreatening	JJ
cord-256217-fnjer0e0	21	23	hyperinflammatory	hyperinflammatory	NN
cord-256217-fnjer0e0	21	24	syndrome	syndrome	NN
cord-256217-fnjer0e0	21	25	leading	lead	VBG
cord-256217-fnjer0e0	21	26	to	to	IN
cord-256217-fnjer0e0	21	27	a	a	DT
cord-256217-fnjer0e0	21	28	rapid	rapid	JJ
cord-256217-fnjer0e0	21	29	multiorgan	multiorgan	NN
cord-256217-fnjer0e0	21	30	deterioration	deterioration	NN
cord-256217-fnjer0e0	21	31	due	due	IN
cord-256217-fnjer0e0	21	32	to	to	IN
cord-256217-fnjer0e0	21	33	severe	severe	JJ
cord-256217-fnjer0e0	21	34	hypercytokinemia	hypercytokinemia	NN
cord-256217-fnjer0e0	21	35	[	[	-LRB-
cord-256217-fnjer0e0	21	36	6	6	CD
cord-256217-fnjer0e0	21	37	]	]	-RRB-
cord-256217-fnjer0e0	21	38	.	.	.
cord-256217-fnjer0e0	22	1	At	at	IN
cord-256217-fnjer0e0	22	2	this	this	DT
cord-256217-fnjer0e0	22	3	stage	stage	NN
cord-256217-fnjer0e0	22	4	,	,	,
cord-256217-fnjer0e0	22	5	can	can	MD
cord-256217-fnjer0e0	22	6	the	the	DT
cord-256217-fnjer0e0	22	7	ocular	ocular	JJ
cord-256217-fnjer0e0	22	8	immune	immune	JJ
cord-256217-fnjer0e0	22	9	system	system	NN
cord-256217-fnjer0e0	22	10	represent	represent	VBP
cord-256217-fnjer0e0	22	11	a	a	DT
cord-256217-fnjer0e0	22	12	valid	valid	JJ
cord-256217-fnjer0e0	22	13	model	model	NN
cord-256217-fnjer0e0	22	14	upon	upon	IN
cord-256217-fnjer0e0	22	15	which	which	WDT
cord-256217-fnjer0e0	22	16	to	to	TO
cord-256217-fnjer0e0	22	17	rely	rely	VB
cord-256217-fnjer0e0	22	18	in	in	IN
cord-256217-fnjer0e0	22	19	order	order	NN
cord-256217-fnjer0e0	22	20	to	to	TO
cord-256217-fnjer0e0	22	21	hypothesize	hypothesize	VB
cord-256217-fnjer0e0	22	22	a	a	DT
cord-256217-fnjer0e0	22	23	possible	possible	JJ
cord-256217-fnjer0e0	22	24	therapeutic	therapeutic	JJ
cord-256217-fnjer0e0	22	25	strategy	strategy	NN
cord-256217-fnjer0e0	22	26	?	?	.
cord-256217-fnjer0e0	23	1	In	in	IN
cord-256217-fnjer0e0	23	2	1990	1990	CD
cord-256217-fnjer0e0	23	3	,	,	,
cord-256217-fnjer0e0	23	4	Robbins	Robbins	NNP
cord-256217-fnjer0e0	23	5	et	et	NNP
cord-256217-fnjer0e0	23	6	al	al	NNP
cord-256217-fnjer0e0	23	7	.	.	NNP
cord-256217-fnjer0e0	23	8	reported	report	VBD
cord-256217-fnjer0e0	23	9	on	on	IN
cord-256217-fnjer0e0	23	10	a	a	DT
cord-256217-fnjer0e0	23	11	possible	possible	JJ
cord-256217-fnjer0e0	23	12	animal	animal	NN
cord-256217-fnjer0e0	23	13	model	model	NN
cord-256217-fnjer0e0	23	14	where	where	WRB
cord-256217-fnjer0e0	23	15	murine	murine	JJ
cord-256217-fnjer0e0	23	16	coronavirus	coronavirus	NN
cord-256217-fnjer0e0	23	17	induced	induce	VBD
cord-256217-fnjer0e0	23	18	an	an	DT
cord-256217-fnjer0e0	23	19	acute	acute	JJ
cord-256217-fnjer0e0	23	20	and	and	CC
cord-256217-fnjer0e0	23	21	long	long	RB
cord-256217-fnjer0e0	23	22	-	-	HYPH
cord-256217-fnjer0e0	23	23	lasting	last	VBG
cord-256217-fnjer0e0	23	24	disease	disease	NN
cord-256217-fnjer0e0	23	25	of	of	IN
cord-256217-fnjer0e0	23	26	the	the	DT
cord-256217-fnjer0e0	23	27	retina	retina	NN
cord-256217-fnjer0e0	23	28	[	[	-LRB-
cord-256217-fnjer0e0	23	29	8	8	CD
cord-256217-fnjer0e0	23	30	]	]	-RRB-
cord-256217-fnjer0e0	23	31	.	.	.
cord-256217-fnjer0e0	24	1	This	this	DT
cord-256217-fnjer0e0	24	2	model	model	NN
cord-256217-fnjer0e0	24	3	was	be	VBD
cord-256217-fnjer0e0	24	4	identified	identify	VBN
cord-256217-fnjer0e0	24	5	as	as	IN
cord-256217-fnjer0e0	24	6	experimental	experimental	JJ
cord-256217-fnjer0e0	24	7	coronavirus	coronavirus	NN
cord-256217-fnjer0e0	24	8	retinopathy	retinopathy	NN
cord-256217-fnjer0e0	24	9	(	(	-LRB-
cord-256217-fnjer0e0	24	10	ECOR	ECOR	NNP
cord-256217-fnjer0e0	24	11	)	)	-RRB-
cord-256217-fnjer0e0	24	12	[	[	-LRB-
cord-256217-fnjer0e0	24	13	8	8	CD
cord-256217-fnjer0e0	24	14	]	]	-RRB-
cord-256217-fnjer0e0	24	15	.	.	.
cord-256217-fnjer0e0	25	1	Few	few	JJ
cord-256217-fnjer0e0	25	2	months	month	NNS
cord-256217-fnjer0e0	25	3	later	later	RB
cord-256217-fnjer0e0	25	4	,	,	,
cord-256217-fnjer0e0	25	5	the	the	DT
cord-256217-fnjer0e0	25	6	same	same	JJ
cord-256217-fnjer0e0	25	7	group	group	NN
cord-256217-fnjer0e0	25	8	of	of	IN
cord-256217-fnjer0e0	25	9	researchers	researcher	NNS
cord-256217-fnjer0e0	25	10	reported	report	VBD
cord-256217-fnjer0e0	25	11	that	that	IN
cord-256217-fnjer0e0	25	12	murine	murine	JJ
cord-256217-fnjer0e0	25	13	coronavirus	coronavirus	NN
cord-256217-fnjer0e0	25	14	had	have	VBD
cord-256217-fnjer0e0	25	15	a	a	DT
cord-256217-fnjer0e0	25	16	specific	specific	JJ
cord-256217-fnjer0e0	25	17	retinotropism	retinotropism	NN
cord-256217-fnjer0e0	25	18	when	when	WRB
cord-256217-fnjer0e0	25	19	introduced	introduce	VBN
cord-256217-fnjer0e0	25	20	by	by	IN
cord-256217-fnjer0e0	25	21	several	several	JJ
cord-256217-fnjer0e0	25	22	direct	direct	JJ
cord-256217-fnjer0e0	25	23	routes	route	NNS
cord-256217-fnjer0e0	25	24	[	[	-LRB-
cord-256217-fnjer0e0	25	25	9	9	CD
cord-256217-fnjer0e0	25	26	]	]	-RRB-
cord-256217-fnjer0e0	25	27	.	.	.
cord-256217-fnjer0e0	26	1	The	the	DT
cord-256217-fnjer0e0	26	2	researchers	researcher	NNS
cord-256217-fnjer0e0	26	3	found	find	VBD
cord-256217-fnjer0e0	26	4	that	that	IN
cord-256217-fnjer0e0	26	5	the	the	DT
cord-256217-fnjer0e0	26	6	viral	viral	JJ
cord-256217-fnjer0e0	26	7	insult	insult	NN
cord-256217-fnjer0e0	26	8	leads	lead	VBZ
cord-256217-fnjer0e0	26	9	to	to	IN
cord-256217-fnjer0e0	26	10	a	a	DT
cord-256217-fnjer0e0	26	11	progressive	progressive	JJ
cord-256217-fnjer0e0	26	12	impairment	impairment	NN
cord-256217-fnjer0e0	26	13	of	of	IN
cord-256217-fnjer0e0	26	14	all	all	PDT
cord-256217-fnjer0e0	26	15	the	the	DT
cord-256217-fnjer0e0	26	16	structures	structure	NNS
cord-256217-fnjer0e0	26	17	of	of	IN
cord-256217-fnjer0e0	26	18	the	the	DT
cord-256217-fnjer0e0	26	19	retinal	retinal	JJ
cord-256217-fnjer0e0	26	20	tissue	tissue	NN
cord-256217-fnjer0e0	26	21	,	,	,
cord-256217-fnjer0e0	26	22	including	include	VBG
cord-256217-fnjer0e0	26	23	photoreceptors	photoreceptor	NNS
cord-256217-fnjer0e0	26	24	and	and	CC
cord-256217-fnjer0e0	26	25	retinal	retinal	JJ
cord-256217-fnjer0e0	26	26	pigment	pigment	NN
cord-256217-fnjer0e0	26	27	epithelium	epithelium	NN
cord-256217-fnjer0e0	26	28	(	(	-LRB-
cord-256217-fnjer0e0	26	29	RPE	RPE	NNP
cord-256217-fnjer0e0	26	30	)	)	-RRB-
cord-256217-fnjer0e0	26	31	.	.	.
cord-256217-fnjer0e0	27	1	Murine	murine	JJ
cord-256217-fnjer0e0	27	2	coronavirus	coronavirus	NN
cord-256217-fnjer0e0	27	3	showed	show	VBD
cord-256217-fnjer0e0	27	4	an	an	DT
cord-256217-fnjer0e0	27	5	evident	evident	JJ
cord-256217-fnjer0e0	27	6	tropism	tropism	NN
cord-256217-fnjer0e0	27	7	to	to	IN
cord-256217-fnjer0e0	27	8	the	the	DT
cord-256217-fnjer0e0	27	9	neural	neural	JJ
cord-256217-fnjer0e0	27	10	tissue	tissue	NN
cord-256217-fnjer0e0	27	11	of	of	IN
cord-256217-fnjer0e0	27	12	the	the	DT
cord-256217-fnjer0e0	27	13	retina	retina	NN
cord-256217-fnjer0e0	27	14	which	which	WDT
cord-256217-fnjer0e0	27	15	was	be	VBD
cord-256217-fnjer0e0	27	16	independent	independent	JJ
cord-256217-fnjer0e0	27	17	of	of	IN
cord-256217-fnjer0e0	27	18	route	route	NN
cord-256217-fnjer0e0	27	19	of	of	IN
cord-256217-fnjer0e0	27	20	inoculation	inoculation	NN
cord-256217-fnjer0e0	27	21	,	,	,
cord-256217-fnjer0e0	27	22	such	such	JJ
cord-256217-fnjer0e0	27	23	as	as	IN
cord-256217-fnjer0e0	27	24	onto	onto	IN
cord-256217-fnjer0e0	27	25	the	the	DT
cord-256217-fnjer0e0	27	26	cornea	cornea	NN
cord-256217-fnjer0e0	27	27	,	,	,
cord-256217-fnjer0e0	27	28	the	the	DT
cord-256217-fnjer0e0	27	29	anterior	anterior	NNP
cord-256217-fnjer0e0	27	30	chamber	chamber	NN
cord-256217-fnjer0e0	27	31	(	(	-LRB-
cord-256217-fnjer0e0	27	32	AC	AC	NNP
cord-256217-fnjer0e0	27	33	)	)	-RRB-
cord-256217-fnjer0e0	27	34	,	,	,
cord-256217-fnjer0e0	27	35	intravitreally	intravitreally	RB
cord-256217-fnjer0e0	27	36	,	,	,
cord-256217-fnjer0e0	27	37	intracerebrally	intracerebrally	RB
cord-256217-fnjer0e0	27	38	,	,	,
cord-256217-fnjer0e0	27	39	or	or	CC
cord-256217-fnjer0e0	27	40	intranasally	intranasally	RB
cord-256217-fnjer0e0	27	41	even	even	RB
cord-256217-fnjer0e0	27	42	.	.	.
cord-256217-fnjer0e0	28	1	Interestingly	interestingly	RB
cord-256217-fnjer0e0	28	2	,	,	,
cord-256217-fnjer0e0	28	3	viral	viral	JJ
cord-256217-fnjer0e0	28	4	antigens	antigen	NNS
cord-256217-fnjer0e0	28	5	were	be	VBD
cord-256217-fnjer0e0	28	6	located	locate	VBN
cord-256217-fnjer0e0	28	7	primarily	primarily	RB
cord-256217-fnjer0e0	28	8	in	in	IN
cord-256217-fnjer0e0	28	9	the	the	DT
cord-256217-fnjer0e0	28	10	inner	inner	JJ
cord-256217-fnjer0e0	28	11	nuclear	nuclear	JJ
cord-256217-fnjer0e0	28	12	layer	layer	NN
cord-256217-fnjer0e0	28	13	,	,	,
cord-256217-fnjer0e0	28	14	photoreceptors	photoreceptor	NNS
cord-256217-fnjer0e0	28	15	,	,	,
cord-256217-fnjer0e0	28	16	Muller	Muller	NNP
cord-256217-fnjer0e0	28	17	cells	cell	NNS
cord-256217-fnjer0e0	28	18	,	,	,
cord-256217-fnjer0e0	28	19	and	and	CC
cord-256217-fnjer0e0	28	20	RPE	RPE	NNP
cord-256217-fnjer0e0	28	21	.	.	.
cord-256217-fnjer0e0	29	1	On	on	IN
cord-256217-fnjer0e0	29	2	the	the	DT
cord-256217-fnjer0e0	29	3	other	other	JJ
cord-256217-fnjer0e0	29	4	hand	hand	NN
cord-256217-fnjer0e0	29	5	,	,	,
cord-256217-fnjer0e0	29	6	at	at	IN
cord-256217-fnjer0e0	29	7	day	day	NN
cord-256217-fnjer0e0	29	8	10	10	CD
cord-256217-fnjer0e0	29	9	,	,	,
cord-256217-fnjer0e0	29	10	ganglion	ganglion	NN
cord-256217-fnjer0e0	29	11	cell	cell	NN
cord-256217-fnjer0e0	29	12	layer	layer	NN
cord-256217-fnjer0e0	29	13	was	be	VBD
cord-256217-fnjer0e0	29	14	the	the	DT
cord-256217-fnjer0e0	29	15	only	only	JJ
cord-256217-fnjer0e0	29	16	and	and	CC
cord-256217-fnjer0e0	29	17	still	still	RB
cord-256217-fnjer0e0	29	18	infected	infect	VBN
cord-256217-fnjer0e0	29	19	,	,	,
cord-256217-fnjer0e0	29	20	indicating	indicate	VBG
cord-256217-fnjer0e0	29	21	a	a	DT
cord-256217-fnjer0e0	29	22	spontaneous	spontaneous	JJ
cord-256217-fnjer0e0	29	23	clearance	clearance	NN
cord-256217-fnjer0e0	29	24	of	of	IN
cord-256217-fnjer0e0	29	25	the	the	DT
cord-256217-fnjer0e0	29	26	virus	virus	NN
cord-256217-fnjer0e0	29	27	from	from	IN
cord-256217-fnjer0e0	29	28	the	the	DT
cord-256217-fnjer0e0	29	29	other	other	JJ
cord-256217-fnjer0e0	29	30	retinal	retinal	JJ
cord-256217-fnjer0e0	29	31	tissues	tissue	NNS
cord-256217-fnjer0e0	29	32	.	.	.
cord-256217-fnjer0e0	30	1	This	this	DT
cord-256217-fnjer0e0	30	2	trend	trend	NN
cord-256217-fnjer0e0	30	3	in	in	IN
cord-256217-fnjer0e0	30	4	affecting	affect	VBG
cord-256217-fnjer0e0	30	5	the	the	DT
cord-256217-fnjer0e0	30	6	nervous	nervous	JJ
cord-256217-fnjer0e0	30	7	system	system	NN
cord-256217-fnjer0e0	30	8	might	may	MD
cord-256217-fnjer0e0	30	9	be	be	VB
cord-256217-fnjer0e0	30	10	the	the	DT
cord-256217-fnjer0e0	30	11	case	case	NN
cord-256217-fnjer0e0	30	12	of	of	IN
cord-256217-fnjer0e0	30	13	SARS	SARS	NNP
cord-256217-fnjer0e0	30	14	-	-	HYPH
cord-256217-fnjer0e0	30	15	COV-2	COV-2	NNP
cord-256217-fnjer0e0	30	16	as	as	RB
cord-256217-fnjer0e0	30	17	well	well	RB
cord-256217-fnjer0e0	30	18	,	,	,
cord-256217-fnjer0e0	30	19	since	since	IN
cord-256217-fnjer0e0	30	20	a	a	DT
cord-256217-fnjer0e0	30	21	recent	recent	JJ
cord-256217-fnjer0e0	30	22	report	report	NN
cord-256217-fnjer0e0	30	23	described	describe	VBD
cord-256217-fnjer0e0	30	24	Guillan	Guillan	NNP
cord-256217-fnjer0e0	30	25	-	-	HYPH
cord-256217-fnjer0e0	30	26	Barrè	Barrè	NNP
cord-256217-fnjer0e0	30	27	syndrome	syndrome	NN
cord-256217-fnjer0e0	30	28	as	as	IN
cord-256217-fnjer0e0	30	29	the	the	DT
cord-256217-fnjer0e0	30	30	first	first	JJ
cord-256217-fnjer0e0	30	31	manifestation	manifestation	NN
cord-256217-fnjer0e0	30	32	of	of	IN
cord-256217-fnjer0e0	30	33	the	the	DT
cord-256217-fnjer0e0	30	34	disease	disease	NN
cord-256217-fnjer0e0	30	35	[	[	-LRB-
cord-256217-fnjer0e0	30	36	10	10	CD
cord-256217-fnjer0e0	30	37	]	]	-RRB-
cord-256217-fnjer0e0	30	38	.	.	.
cord-256217-fnjer0e0	31	1	Interestingly	interestingly	RB
cord-256217-fnjer0e0	31	2	,	,	,
cord-256217-fnjer0e0	31	3	infection	infection	NN
cord-256217-fnjer0e0	31	4	induces	induce	VBZ
cord-256217-fnjer0e0	31	5	fibrosis	fibrosis	NN
cord-256217-fnjer0e0	31	6	of	of	IN
cord-256217-fnjer0e0	31	7	RPE	RPE	NNP
cord-256217-fnjer0e0	31	8	cells	cell	NNS
cord-256217-fnjer0e0	31	9	as	as	RB
cord-256217-fnjer0e0	31	10	well	well	RB
cord-256217-fnjer0e0	31	11	as	as	IN
cord-256217-fnjer0e0	31	12	moderate	moderate	JJ
cord-256217-fnjer0e0	31	13	retinal	retinal	JJ
cord-256217-fnjer0e0	31	14	atrophy	atrophy	NN
cord-256217-fnjer0e0	31	15	in	in	IN
cord-256217-fnjer0e0	31	16	the	the	DT
cord-256217-fnjer0e0	31	17	long	long	JJ
cord-256217-fnjer0e0	31	18	term	term	NN
cord-256217-fnjer0e0	31	19	,	,	,
cord-256217-fnjer0e0	31	20	which	which	WDT
cord-256217-fnjer0e0	31	21	suggests	suggest	VBZ
cord-256217-fnjer0e0	31	22	a	a	DT
cord-256217-fnjer0e0	31	23	certain	certain	JJ
cord-256217-fnjer0e0	31	24	role	role	NN
cord-256217-fnjer0e0	31	25	played	play	VBN
cord-256217-fnjer0e0	31	26	by	by	IN
cord-256217-fnjer0e0	31	27	fibroblasts	fibroblast	NNS
cord-256217-fnjer0e0	31	28	in	in	IN
cord-256217-fnjer0e0	31	29	attempting	attempt	VBG
cord-256217-fnjer0e0	31	30	a	a	DT
cord-256217-fnjer0e0	31	31	repair	repair	NN
cord-256217-fnjer0e0	31	32	of	of	IN
cord-256217-fnjer0e0	31	33	the	the	DT
cord-256217-fnjer0e0	31	34	damaged	damage	VBN
cord-256217-fnjer0e0	31	35	tissue	tissue	NN
cord-256217-fnjer0e0	31	36	.	.	.
cord-256217-fnjer0e0	32	1	Although	although	IN
cord-256217-fnjer0e0	32	2	ECOR	ECOR	NNP
cord-256217-fnjer0e0	32	3	was	be	VBD
cord-256217-fnjer0e0	32	4	used	use	VBN
cord-256217-fnjer0e0	32	5	to	to	TO
cord-256217-fnjer0e0	32	6	study	study	VB
cord-256217-fnjer0e0	32	7	retinal	retinal	JJ
cord-256217-fnjer0e0	32	8	degeneration	degeneration	NN
cord-256217-fnjer0e0	32	9	specifically	specifically	RB
cord-256217-fnjer0e0	32	10	,	,	,
cord-256217-fnjer0e0	32	11	it	-PRON-	PRP
cord-256217-fnjer0e0	32	12	might	may	MD
cord-256217-fnjer0e0	32	13	represent	represent	VB
cord-256217-fnjer0e0	32	14	a	a	DT
cord-256217-fnjer0e0	32	15	possible	possible	JJ
cord-256217-fnjer0e0	32	16	experimental	experimental	JJ
cord-256217-fnjer0e0	32	17	model	model	NN
cord-256217-fnjer0e0	32	18	for	for	IN
cord-256217-fnjer0e0	32	19	interesting	interesting	JJ
cord-256217-fnjer0e0	32	20	speculations	speculation	NNS
cord-256217-fnjer0e0	32	21	on	on	IN
cord-256217-fnjer0e0	32	22	how	how	WRB
cord-256217-fnjer0e0	32	23	to	to	TO
cord-256217-fnjer0e0	32	24	approach	approach	VB
cord-256217-fnjer0e0	32	25	severe	severe	JJ
cord-256217-fnjer0e0	32	26	SARS	SARS	NNP
cord-256217-fnjer0e0	32	27	-	-	HYPH
cord-256217-fnjer0e0	32	28	COV-2	COV-2	NNP
cord-256217-fnjer0e0	32	29	pulmonary	pulmonary	JJ
cord-256217-fnjer0e0	32	30	complications	complication	NNS
cord-256217-fnjer0e0	32	31	.	.	.
cord-256217-fnjer0e0	33	1	Going	go	VBG
cord-256217-fnjer0e0	33	2	through	through	IN
cord-256217-fnjer0e0	33	3	the	the	DT
cord-256217-fnjer0e0	33	4	medical	medical	JJ
cord-256217-fnjer0e0	33	5	literature	literature	NN
cord-256217-fnjer0e0	33	6	,	,	,
cord-256217-fnjer0e0	33	7	very	very	RB
cord-256217-fnjer0e0	33	8	little	little	JJ
cord-256217-fnjer0e0	33	9	information	information	NN
cord-256217-fnjer0e0	33	10	is	be	VBZ
cord-256217-fnjer0e0	33	11	available	available	JJ
cord-256217-fnjer0e0	33	12	on	on	IN
cord-256217-fnjer0e0	33	13	the	the	DT
cord-256217-fnjer0e0	33	14	possible	possible	JJ
cord-256217-fnjer0e0	33	15	role	role	NN
cord-256217-fnjer0e0	33	16	played	play	VBN
cord-256217-fnjer0e0	33	17	by	by	IN
cord-256217-fnjer0e0	33	18	the	the	DT
cord-256217-fnjer0e0	33	19	immune	immune	JJ
cord-256217-fnjer0e0	33	20	system	system	NN
cord-256217-fnjer0e0	33	21	in	in	IN
cord-256217-fnjer0e0	33	22	lung	lung	NN
cord-256217-fnjer0e0	33	23	involvement	involvement	NN
cord-256217-fnjer0e0	33	24	,	,	,
cord-256217-fnjer0e0	33	25	which	which	WDT
cord-256217-fnjer0e0	33	26	shows	show	VBZ
cord-256217-fnjer0e0	33	27	moderate	moderate	JJ
cord-256217-fnjer0e0	33	28	multinucleated	multinucleated	JJ
cord-256217-fnjer0e0	33	29	giant	giant	JJ
cord-256217-fnjer0e0	33	30	cells	cell	NNS
cord-256217-fnjer0e0	33	31	,	,	,
cord-256217-fnjer0e0	33	32	minimal	minimal	JJ
cord-256217-fnjer0e0	33	33	lymphocytes	lymphocyte	NNS
cord-256217-fnjer0e0	33	34	,	,	,
cord-256217-fnjer0e0	33	35	eosinophils	eosinophil	NNS
cord-256217-fnjer0e0	33	36	,	,	,
cord-256217-fnjer0e0	33	37	CD4-positive	CD4-positive	NNP
cord-256217-fnjer0e0	33	38	T	t	NN
cord-256217-fnjer0e0	33	39	cells	cell	NNS
cord-256217-fnjer0e0	33	40	,	,	,
cord-256217-fnjer0e0	33	41	and	and	CC
cord-256217-fnjer0e0	33	42	neutrophils	neutrophil	NNS
cord-256217-fnjer0e0	33	43	[	[	-LRB-
cord-256217-fnjer0e0	33	44	11	11	CD
cord-256217-fnjer0e0	33	45	]	]	-RRB-
cord-256217-fnjer0e0	33	46	.	.	.
cord-256217-fnjer0e0	34	1	Lungs	lung	NNS
cord-256217-fnjer0e0	34	2	blood	blood	NN
cord-256217-fnjer0e0	34	3	vessels	vessel	NNS
cord-256217-fnjer0e0	34	4	of	of	IN
cord-256217-fnjer0e0	34	5	alveolar	alveolar	NN
cord-256217-fnjer0e0	34	6	septum	septum	NN
cord-256217-fnjer0e0	34	7	are	be	VBP
cord-256217-fnjer0e0	34	8	congested	congested	JJ
cord-256217-fnjer0e0	34	9	,	,	,
cord-256217-fnjer0e0	34	10	edematous	edematous	JJ
cord-256217-fnjer0e0	34	11	,	,	,
cord-256217-fnjer0e0	34	12	and	and	CC
cord-256217-fnjer0e0	34	13	widened	widen	VBD
cord-256217-fnjer0e0	34	14	,	,	,
cord-256217-fnjer0e0	34	15	with	with	IN
cord-256217-fnjer0e0	34	16	modest	modest	JJ
cord-256217-fnjer0e0	34	17	infiltration	infiltration	NN
cord-256217-fnjer0e0	34	18	of	of	IN
cord-256217-fnjer0e0	34	19	monocytes	monocyte	NNS
cord-256217-fnjer0e0	34	20	and	and	CC
cord-256217-fnjer0e0	34	21	lymphocytes	lymphocyte	NNS
cord-256217-fnjer0e0	34	22	.	.	.
cord-256217-fnjer0e0	35	1	Hyaline	hyaline	JJ
cord-256217-fnjer0e0	35	2	thrombi	thrombi	NN
cord-256217-fnjer0e0	35	3	are	be	VBP
cord-256217-fnjer0e0	35	4	also	also	RB
cord-256217-fnjer0e0	35	5	found	find	VBN
cord-256217-fnjer0e0	35	6	in	in	IN
cord-256217-fnjer0e0	35	7	a	a	DT
cord-256217-fnjer0e0	35	8	minority	minority	NN
cord-256217-fnjer0e0	35	9	of	of	IN
cord-256217-fnjer0e0	35	10	microvessels	microvessel	NNS
cord-256217-fnjer0e0	35	11	,	,	,
cord-256217-fnjer0e0	35	12	as	as	RB
cord-256217-fnjer0e0	35	13	well	well	RB
cord-256217-fnjer0e0	35	14	as	as	IN
cord-256217-fnjer0e0	35	15	local	local	JJ
cord-256217-fnjer0e0	35	16	hemorrhage	hemorrhage	NN
cord-256217-fnjer0e0	35	17	in	in	IN
cord-256217-fnjer0e0	35	18	lung	lung	NN
cord-256217-fnjer0e0	35	19	tissue	tissue	NN
cord-256217-fnjer0e0	35	20	,	,	,
cord-256217-fnjer0e0	35	21	organization	organization	NN
cord-256217-fnjer0e0	35	22	of	of	IN
cord-256217-fnjer0e0	35	23	exudates	exudate	NNS
cord-256217-fnjer0e0	35	24	in	in	IN
cord-256217-fnjer0e0	35	25	some	some	DT
cord-256217-fnjer0e0	35	26	alveolar	alveolar	JJ
cord-256217-fnjer0e0	35	27	cavities	cavity	NNS
cord-256217-fnjer0e0	35	28	,	,	,
cord-256217-fnjer0e0	35	29	and	and	CC
cord-256217-fnjer0e0	35	30	pulmonary	pulmonary	JJ
cord-256217-fnjer0e0	35	31	interstitial	interstitial	JJ
cord-256217-fnjer0e0	35	32	fibrosis	fibrosis	NN
cord-256217-fnjer0e0	35	33	.	.	.
cord-256217-fnjer0e0	36	1	On	on	IN
cord-256217-fnjer0e0	36	2	the	the	DT
cord-256217-fnjer0e0	36	3	other	other	JJ
cord-256217-fnjer0e0	36	4	hand	hand	NN
cord-256217-fnjer0e0	36	5	,	,	,
cord-256217-fnjer0e0	36	6	all	all	PDT
cord-256217-fnjer0e0	36	7	those	those	DT
cord-256217-fnjer0e0	36	8	findings	finding	NNS
cord-256217-fnjer0e0	36	9	were	be	VBD
cord-256217-fnjer0e0	36	10	taken	take	VBN
cord-256217-fnjer0e0	36	11	postmortem	postmortem	JJ
cord-256217-fnjer0e0	36	12	and	and	CC
cord-256217-fnjer0e0	36	13	there	there	EX
cord-256217-fnjer0e0	36	14	is	be	VBZ
cord-256217-fnjer0e0	36	15	lack	lack	NN
cord-256217-fnjer0e0	36	16	of	of	IN
cord-256217-fnjer0e0	36	17	data	datum	NNS
cord-256217-fnjer0e0	36	18	on	on	IN
cord-256217-fnjer0e0	36	19	different	different	JJ
cord-256217-fnjer0e0	36	20	phases	phase	NNS
cord-256217-fnjer0e0	36	21	of	of	IN
cord-256217-fnjer0e0	36	22	the	the	DT
cord-256217-fnjer0e0	36	23	disease	disease	NN
cord-256217-fnjer0e0	36	24	.	.	.
cord-256217-fnjer0e0	37	1	Looking	look	VBG
cord-256217-fnjer0e0	37	2	at	at	IN
cord-256217-fnjer0e0	37	3	the	the	DT
cord-256217-fnjer0e0	37	4	ECOR	ECOR	NNP
cord-256217-fnjer0e0	37	5	model	model	NN
cord-256217-fnjer0e0	37	6	,	,	,
cord-256217-fnjer0e0	37	7	it	-PRON-	PRP
cord-256217-fnjer0e0	37	8	gives	give	VBZ
cord-256217-fnjer0e0	37	9	the	the	DT
cord-256217-fnjer0e0	37	10	impression	impression	NN
cord-256217-fnjer0e0	37	11	that	that	IN
cord-256217-fnjer0e0	37	12	coronavirus	coronavirus	NN
cord-256217-fnjer0e0	37	13	creates	create	VBZ
cord-256217-fnjer0e0	37	14	two	two	CD
cord-256217-fnjer0e0	37	15	different	different	JJ
cord-256217-fnjer0e0	37	16	phases	phase	NNS
cord-256217-fnjer0e0	37	17	:	:	:
cord-256217-fnjer0e0	37	18	the	the	DT
cord-256217-fnjer0e0	37	19	first	first	JJ
cord-256217-fnjer0e0	37	20	is	be	VBZ
cord-256217-fnjer0e0	37	21	represented	represent	VBN
cord-256217-fnjer0e0	37	22	by	by	IN
cord-256217-fnjer0e0	37	23	the	the	DT
cord-256217-fnjer0e0	37	24	primary	primary	JJ
cord-256217-fnjer0e0	37	25	infection	infection	NN
cord-256217-fnjer0e0	37	26	which	which	WDT
cord-256217-fnjer0e0	37	27	induces	induce	VBZ
cord-256217-fnjer0e0	37	28	the	the	DT
cord-256217-fnjer0e0	37	29	triggering	triggering	NN
cord-256217-fnjer0e0	37	30	of	of	IN
cord-256217-fnjer0e0	37	31	the	the	DT
cord-256217-fnjer0e0	37	32	immune	immune	JJ
cord-256217-fnjer0e0	37	33	system	system	NN
cord-256217-fnjer0e0	37	34	,	,	,
cord-256217-fnjer0e0	37	35	while	while	IN
cord-256217-fnjer0e0	37	36	the	the	DT
cord-256217-fnjer0e0	37	37	second	second	JJ
cord-256217-fnjer0e0	37	38	phase	phase	NN
cord-256217-fnjer0e0	37	39	is	be	VBZ
cord-256217-fnjer0e0	37	40	likely	likely	JJ
cord-256217-fnjer0e0	37	41	to	to	TO
cord-256217-fnjer0e0	37	42	be	be	VB
cord-256217-fnjer0e0	37	43	an	an	DT
cord-256217-fnjer0e0	37	44	autoimmune	autoimmune	JJ
cord-256217-fnjer0e0	37	45	disease	disease	NN
cord-256217-fnjer0e0	37	46	where	where	WRB
cord-256217-fnjer0e0	37	47	the	the	DT
cord-256217-fnjer0e0	37	48	role	role	NN
cord-256217-fnjer0e0	37	49	of	of	IN
cord-256217-fnjer0e0	37	50	the	the	DT
cord-256217-fnjer0e0	37	51	severe	severe	JJ
cord-256217-fnjer0e0	37	52	postviral	postviral	JJ
cord-256217-fnjer0e0	37	53	inflammation	inflammation	NN
cord-256217-fnjer0e0	37	54	represents	represent	VBZ
cord-256217-fnjer0e0	37	55	a	a	DT
cord-256217-fnjer0e0	37	56	severe	severe	JJ
cord-256217-fnjer0e0	37	57	occurrence	occurrence	NN
cord-256217-fnjer0e0	37	58	worth	worth	NN
cord-256217-fnjer0e0	37	59	of	of	IN
cord-256217-fnjer0e0	37	60	prompt	prompt	JJ
cord-256217-fnjer0e0	37	61	intervention	intervention	NN
cord-256217-fnjer0e0	37	62	.	.	.
cord-256217-fnjer0e0	38	1	Coronavirus	Coronavirus	NNP
cord-256217-fnjer0e0	38	2	animal	animal	NN
cord-256217-fnjer0e0	38	3	model	model	NN
cord-256217-fnjer0e0	38	4	suggests	suggest	VBZ
cord-256217-fnjer0e0	38	5	that	that	IN
cord-256217-fnjer0e0	38	6	such	such	JJ
cord-256217-fnjer0e0	38	7	hypothesis	hypothesis	NN
cord-256217-fnjer0e0	38	8	might	may	MD
cord-256217-fnjer0e0	38	9	be	be	VB
cord-256217-fnjer0e0	38	10	justified	justify	VBN
cord-256217-fnjer0e0	38	11	[	[	-LRB-
cord-256217-fnjer0e0	38	12	9	9	CD
cord-256217-fnjer0e0	38	13	]	]	-RRB-
cord-256217-fnjer0e0	38	14	:	:	:
cord-256217-fnjer0e0	38	15	as	as	IN
cord-256217-fnjer0e0	38	16	we	-PRON-	PRP
cord-256217-fnjer0e0	38	17	previously	previously	RB
cord-256217-fnjer0e0	38	18	said	say	VBD
cord-256217-fnjer0e0	38	19	,	,	,
cord-256217-fnjer0e0	38	20	Coronavirus	Coronavirus	NNP
cord-256217-fnjer0e0	38	21	was	be	VBD
cord-256217-fnjer0e0	38	22	detected	detect	VBN
cord-256217-fnjer0e0	38	23	into	into	IN
cord-256217-fnjer0e0	38	24	the	the	DT
cord-256217-fnjer0e0	38	25	ganglion	ganglion	NN
cord-256217-fnjer0e0	38	26	cell	cell	NN
cord-256217-fnjer0e0	38	27	layer	layer	NN
cord-256217-fnjer0e0	38	28	only	only	RB
cord-256217-fnjer0e0	38	29	after	after	IN
cord-256217-fnjer0e0	38	30	10	10	CD
cord-256217-fnjer0e0	38	31	days	day	NNS
cord-256217-fnjer0e0	38	32	,	,	,
cord-256217-fnjer0e0	38	33	even	even	RB
cord-256217-fnjer0e0	38	34	though	though	IN
cord-256217-fnjer0e0	38	35	in	in	IN
cord-256217-fnjer0e0	38	36	26	26	CD
cord-256217-fnjer0e0	38	37	%	%	NN
cord-256217-fnjer0e0	38	38	of	of	IN
cord-256217-fnjer0e0	38	39	the	the	DT
cord-256217-fnjer0e0	38	40	experimental	experimental	JJ
cord-256217-fnjer0e0	38	41	animals	animal	NNS
cord-256217-fnjer0e0	38	42	a	a	DT
cord-256217-fnjer0e0	38	43	severe	severe	JJ
cord-256217-fnjer0e0	38	44	and	and	CC
cord-256217-fnjer0e0	38	45	massive	massive	JJ
cord-256217-fnjer0e0	38	46	inflammation	inflammation	NN
cord-256217-fnjer0e0	38	47	of	of	IN
cord-256217-fnjer0e0	38	48	most	most	JJS
cord-256217-fnjer0e0	38	49	ocular	ocular	JJ
cord-256217-fnjer0e0	38	50	structures	structure	NNS
cord-256217-fnjer0e0	38	51	was	be	VBD
cord-256217-fnjer0e0	38	52	observed	observe	VBN
cord-256217-fnjer0e0	38	53	.	.	.
cord-256217-fnjer0e0	39	1	The	the	DT
cord-256217-fnjer0e0	39	2	authors	author	NNS
cord-256217-fnjer0e0	39	3	speculated	speculate	VBD
cord-256217-fnjer0e0	39	4	that	that	IN
cord-256217-fnjer0e0	39	5	gliosis	gliosis	NNP
cord-256217-fnjer0e0	39	6	might	may	MD
cord-256217-fnjer0e0	39	7	have	have	VB
cord-256217-fnjer0e0	39	8	been	be	VBN
cord-256217-fnjer0e0	39	9	present	present	JJ
cord-256217-fnjer0e0	39	10	in	in	IN
cord-256217-fnjer0e0	39	11	affected	affected	JJ
cord-256217-fnjer0e0	39	12	retinas	retina	NNS
cord-256217-fnjer0e0	39	13	as	as	IN
cord-256217-fnjer0e0	39	14	the	the	DT
cord-256217-fnjer0e0	39	15	result	result	NN
cord-256217-fnjer0e0	39	16	of	of	IN
cord-256217-fnjer0e0	39	17	breakdown	breakdown	NN
cord-256217-fnjer0e0	39	18	of	of	IN
cord-256217-fnjer0e0	39	19	the	the	DT
cord-256217-fnjer0e0	39	20	blood	blood	NN
cord-256217-fnjer0e0	39	21	-	-	HYPH
cord-256217-fnjer0e0	39	22	ocular	ocular	JJ
cord-256217-fnjer0e0	39	23	barrier	barrier	NN
cord-256217-fnjer0e0	39	24	which	which	WDT
cord-256217-fnjer0e0	39	25	can	can	MD
cord-256217-fnjer0e0	39	26	allow	allow	VB
cord-256217-fnjer0e0	39	27	coronavirus	coronavirus	NN
cord-256217-fnjer0e0	39	28	-	-	HYPH
cord-256217-fnjer0e0	39	29	bearing	bear	VBG
cord-256217-fnjer0e0	39	30	macrophages	macrophage	NNS
cord-256217-fnjer0e0	39	31	to	to	TO
cord-256217-fnjer0e0	39	32	access	access	VB
cord-256217-fnjer0e0	39	33	the	the	DT
cord-256217-fnjer0e0	39	34	eye	eye	NN
cord-256217-fnjer0e0	39	35	.	.	.
cord-256217-fnjer0e0	40	1	Regarding	regard	VBG
cord-256217-fnjer0e0	40	2	the	the	DT
cord-256217-fnjer0e0	40	3	specific	specific	JJ
cord-256217-fnjer0e0	40	4	vascular	vascular	JJ
cord-256217-fnjer0e0	40	5	involvement	involvement	NN
cord-256217-fnjer0e0	40	6	,	,	,
cord-256217-fnjer0e0	40	7	massive	massive	JJ
cord-256217-fnjer0e0	40	8	inflammation	inflammation	NN
cord-256217-fnjer0e0	40	9	leads	lead	VBZ
cord-256217-fnjer0e0	40	10	to	to	IN
cord-256217-fnjer0e0	40	11	damage	damage	VB
cord-256217-fnjer0e0	40	12	to	to	IN
cord-256217-fnjer0e0	40	13	the	the	DT
cord-256217-fnjer0e0	40	14	walls	wall	NNS
cord-256217-fnjer0e0	40	15	of	of	IN
cord-256217-fnjer0e0	40	16	veins	vein	NNS
cord-256217-fnjer0e0	40	17	,	,	,
cord-256217-fnjer0e0	40	18	evidenced	evidence	VBN
cord-256217-fnjer0e0	40	19	by	by	IN
cord-256217-fnjer0e0	40	20	loss	loss	NN
cord-256217-fnjer0e0	40	21	of	of	IN
cord-256217-fnjer0e0	40	22	continuity	continuity	NN
cord-256217-fnjer0e0	40	23	and	and	CC
cord-256217-fnjer0e0	40	24	erythrocytes	erythrocyte	VBZ
cord-256217-fnjer0e0	40	25	extravasation	extravasation	NN
cord-256217-fnjer0e0	40	26	into	into	IN
cord-256217-fnjer0e0	40	27	the	the	DT
cord-256217-fnjer0e0	40	28	surrounding	surround	VBG
cord-256217-fnjer0e0	40	29	tissue	tissue	NN
cord-256217-fnjer0e0	40	30	.	.	.
cord-256217-fnjer0e0	41	1	Similarly	similarly	RB
cord-256217-fnjer0e0	41	2	,	,	,
cord-256217-fnjer0e0	41	3	the	the	DT
cord-256217-fnjer0e0	41	4	lung	lung	NN
cord-256217-fnjer0e0	41	5	polythrombosis	polythrombosis	NN
cord-256217-fnjer0e0	41	6	observed	observe	VBD
cord-256217-fnjer0e0	41	7	in	in	IN
cord-256217-fnjer0e0	41	8	SARS	SARS	NNP
cord-256217-fnjer0e0	41	9	-	-	HYPH
cord-256217-fnjer0e0	41	10	COV-2	COV-2	NNP
cord-256217-fnjer0e0	41	11	cases	case	NNS
cord-256217-fnjer0e0	41	12	seems	seem	VBZ
cord-256217-fnjer0e0	41	13	to	to	TO
cord-256217-fnjer0e0	41	14	be	be	VB
cord-256217-fnjer0e0	41	15	a	a	DT
cord-256217-fnjer0e0	41	16	result	result	NN
cord-256217-fnjer0e0	41	17	of	of	IN
cord-256217-fnjer0e0	41	18	the	the	DT
cord-256217-fnjer0e0	41	19	interstitial	interstitial	JJ
cord-256217-fnjer0e0	41	20	inflammation	inflammation	NN
cord-256217-fnjer0e0	41	21	where	where	WRB
cord-256217-fnjer0e0	41	22	hyaline	hyaline	JJ
cord-256217-fnjer0e0	41	23	thrombi	thrombi	NN
cord-256217-fnjer0e0	41	24	of	of	IN
cord-256217-fnjer0e0	41	25	the	the	DT
cord-256217-fnjer0e0	41	26	microvessels	microvessel	NNS
cord-256217-fnjer0e0	41	27	might	may	MD
cord-256217-fnjer0e0	41	28	be	be	VB
cord-256217-fnjer0e0	41	29	induced	induce	VBN
cord-256217-fnjer0e0	41	30	by	by	IN
cord-256217-fnjer0e0	41	31	the	the	DT
cord-256217-fnjer0e0	41	32	perivasculitis	perivasculitis	NN
cord-256217-fnjer0e0	41	33	affecting	affect	VBG
cord-256217-fnjer0e0	41	34	the	the	DT
cord-256217-fnjer0e0	41	35	vessels	vessel	NNS
cord-256217-fnjer0e0	41	36	walls	wall	NNS
cord-256217-fnjer0e0	41	37	embedded	embed	VBN
cord-256217-fnjer0e0	41	38	into	into	IN
cord-256217-fnjer0e0	41	39	the	the	DT
cord-256217-fnjer0e0	41	40	affected	affected	JJ
cord-256217-fnjer0e0	41	41	tissue	tissue	NN
cord-256217-fnjer0e0	41	42	[	[	-LRB-
cord-256217-fnjer0e0	41	43	11	11	CD
cord-256217-fnjer0e0	41	44	]	]	-RRB-
cord-256217-fnjer0e0	41	45	.	.	.
cord-256217-fnjer0e0	42	1	At	at	IN
cord-256217-fnjer0e0	42	2	this	this	DT
cord-256217-fnjer0e0	42	3	stage	stage	NN
cord-256217-fnjer0e0	42	4	,	,	,
cord-256217-fnjer0e0	42	5	the	the	DT
cord-256217-fnjer0e0	42	6	therapeutic	therapeutic	JJ
cord-256217-fnjer0e0	42	7	strategy	strategy	NN
cord-256217-fnjer0e0	42	8	is	be	VBZ
cord-256217-fnjer0e0	42	9	still	still	RB
cord-256217-fnjer0e0	42	10	opened	open	VBN
cord-256217-fnjer0e0	42	11	for	for	IN
cord-256217-fnjer0e0	42	12	discussion	discussion	NN
cord-256217-fnjer0e0	42	13	and	and	CC
cord-256217-fnjer0e0	42	14	might	may	MD
cord-256217-fnjer0e0	42	15	offer	offer	VB
cord-256217-fnjer0e0	42	16	a	a	DT
cord-256217-fnjer0e0	42	17	series	series	NN
cord-256217-fnjer0e0	42	18	of	of	IN
cord-256217-fnjer0e0	42	19	fascinating	fascinating	JJ
cord-256217-fnjer0e0	42	20	hypotheses	hypothesis	NNS
cord-256217-fnjer0e0	42	21	for	for	IN
cord-256217-fnjer0e0	42	22	a	a	DT
cord-256217-fnjer0e0	42	23	rescue	rescue	NN
cord-256217-fnjer0e0	42	24	treatment	treatment	NN
cord-256217-fnjer0e0	42	25	in	in	IN
cord-256217-fnjer0e0	42	26	severe	severe	JJ
cord-256217-fnjer0e0	42	27	SARS	SARS	NNP
cord-256217-fnjer0e0	42	28	-	-	HYPH
cord-256217-fnjer0e0	42	29	COV-2	COV-2	NNP
cord-256217-fnjer0e0	42	30	pneumonia	pneumonia	NN
cord-256217-fnjer0e0	42	31	.	.	.
cord-256217-fnjer0e0	43	1	Albeit	albeit	IN
cord-256217-fnjer0e0	43	2	it	-PRON-	PRP
cord-256217-fnjer0e0	43	3	is	be	VBZ
cord-256217-fnjer0e0	43	4	true	true	JJ
cord-256217-fnjer0e0	43	5	that	that	IN
cord-256217-fnjer0e0	43	6	anti	anti	JJ
cord-256217-fnjer0e0	43	7	-	-	JJ
cord-256217-fnjer0e0	43	8	IL-6	il-6	JJ
cord-256217-fnjer0e0	43	9	receptor	receptor	NN
cord-256217-fnjer0e0	43	10	monoclonal	monoclonal	JJ
cord-256217-fnjer0e0	43	11	antibody	antibody	NN
cord-256217-fnjer0e0	43	12	has	have	VBZ
cord-256217-fnjer0e0	43	13	given	give	VBN
cord-256217-fnjer0e0	43	14	promising	promising	JJ
cord-256217-fnjer0e0	43	15	results	result	NNS
cord-256217-fnjer0e0	43	16	for	for	IN
cord-256217-fnjer0e0	43	17	the	the	DT
cord-256217-fnjer0e0	43	18	control	control	NN
cord-256217-fnjer0e0	43	19	of	of	IN
cord-256217-fnjer0e0	43	20	severe	severe	JJ
cord-256217-fnjer0e0	43	21	SARS	SARS	NNP
cord-256217-fnjer0e0	43	22	-	-	HYPH
cord-256217-fnjer0e0	43	23	COV-2	COV-2	NNP
cord-256217-fnjer0e0	43	24	pneumonia	pneumonia	NN
cord-256217-fnjer0e0	44	1	,	,	,
cord-256217-fnjer0e0	44	2	it	-PRON-	PRP
cord-256217-fnjer0e0	44	3	is	be	VBZ
cord-256217-fnjer0e0	44	4	interesting	interesting	JJ
cord-256217-fnjer0e0	44	5	to	to	TO
cord-256217-fnjer0e0	44	6	notice	notice	VB
cord-256217-fnjer0e0	44	7	that	that	IN
cord-256217-fnjer0e0	44	8	retinal	retinal	JJ
cord-256217-fnjer0e0	44	9	degeneration	degeneration	NN
cord-256217-fnjer0e0	44	10	in	in	IN
cord-256217-fnjer0e0	44	11	ECOR	ECOR	NNP
cord-256217-fnjer0e0	44	12	is	be	VBZ
cord-256217-fnjer0e0	44	13	associated	associate	VBN
cord-256217-fnjer0e0	44	14	with	with	IN
cord-256217-fnjer0e0	44	15	an	an	DT
cord-256217-fnjer0e0	44	16	evident	evident	JJ
cord-256217-fnjer0e0	44	17	increase	increase	NN
cord-256217-fnjer0e0	44	18	in	in	IN
cord-256217-fnjer0e0	44	19	TNF	TNF	NNP
cord-256217-fnjer0e0	44	20	-	-	HYPH
cord-256217-fnjer0e0	44	21	alpha	alpha	NN
cord-256217-fnjer0e0	44	22	,	,	,
cord-256217-fnjer0e0	44	23	as	as	RB
cord-256217-fnjer0e0	44	24	well	well	RB
cord-256217-fnjer0e0	44	25	as	as	IN
cord-256217-fnjer0e0	44	26	soluble	soluble	JJ
cord-256217-fnjer0e0	44	27	TNFR2	tnfr2	NN
cord-256217-fnjer0e0	44	28	,	,	,
cord-256217-fnjer0e0	44	29	inducing	induce	VBG
cord-256217-fnjer0e0	44	30	an	an	DT
cord-256217-fnjer0e0	44	31	anomaly	anomaly	NN
cord-256217-fnjer0e0	44	32	of	of	IN
cord-256217-fnjer0e0	44	33	TNF	tnf	NN
cord-256217-fnjer0e0	44	34	-	-	HYPH
cord-256217-fnjer0e0	44	35	alpha	alpha	NN
cord-256217-fnjer0e0	44	36	signaling	signaling	NN
cord-256217-fnjer0e0	44	37	[	[	-LRB-
cord-256217-fnjer0e0	44	38	12	12	CD
cord-256217-fnjer0e0	44	39	]	]	-RRB-
cord-256217-fnjer0e0	44	40	.	.	.
cord-256217-fnjer0e0	45	1	The	the	DT
cord-256217-fnjer0e0	45	2	clinical	clinical	JJ
cord-256217-fnjer0e0	45	3	picture	picture	NN
cord-256217-fnjer0e0	45	4	offered	offer	VBN
cord-256217-fnjer0e0	45	5	by	by	IN
cord-256217-fnjer0e0	45	6	SARS	SARS	NNP
cord-256217-fnjer0e0	45	7	-	-	HYPH
cord-256217-fnjer0e0	45	8	COV-2	COV-2	NNP
cord-256217-fnjer0e0	45	9	pneumonia	pneumonia	NN
cord-256217-fnjer0e0	45	10	seems	seem	VBZ
cord-256217-fnjer0e0	45	11	to	to	TO
cord-256217-fnjer0e0	45	12	present	present	VB
cord-256217-fnjer0e0	45	13	a	a	DT
cord-256217-fnjer0e0	45	14	series	series	NN
cord-256217-fnjer0e0	45	15	of	of	IN
cord-256217-fnjer0e0	45	16	similarities	similarity	NNS
cord-256217-fnjer0e0	45	17	to	to	IN
cord-256217-fnjer0e0	45	18	so	so	RB
cord-256217-fnjer0e0	45	19	-	-	HYPH
cord-256217-fnjer0e0	45	20	called	call	VBN
cord-256217-fnjer0e0	45	21	interstitial	interstitial	JJ
cord-256217-fnjer0e0	45	22	pneumonia	pneumonia	NN
cord-256217-fnjer0e0	45	23	with	with	IN
cord-256217-fnjer0e0	45	24	autoimmune	autoimmune	JJ
cord-256217-fnjer0e0	45	25	features	feature	NNS
cord-256217-fnjer0e0	46	1	(	(	-LRB-
cord-256217-fnjer0e0	46	2	IPAF	IPAF	NNP
cord-256217-fnjer0e0	46	3	)	)	-RRB-
cord-256217-fnjer0e0	46	4	recently	recently	RB
cord-256217-fnjer0e0	46	5	described	describe	VBN
cord-256217-fnjer0e0	46	6	by	by	IN
cord-256217-fnjer0e0	46	7	the	the	DT
cord-256217-fnjer0e0	46	8	European	European	NNP
cord-256217-fnjer0e0	46	9	Respiratory	Respiratory	NNP
cord-256217-fnjer0e0	46	10	Society	Society	NNP
cord-256217-fnjer0e0	46	11	and	and	CC
cord-256217-fnjer0e0	46	12	the	the	DT
cord-256217-fnjer0e0	46	13	American	American	NNP
cord-256217-fnjer0e0	46	14	Thoracic	Thoracic	NNP
cord-256217-fnjer0e0	46	15	Society	Society	NNP
cord-256217-fnjer0e0	46	16	[	[	-LRB-
cord-256217-fnjer0e0	46	17	13	13	CD
cord-256217-fnjer0e0	46	18	]	]	-RRB-
cord-256217-fnjer0e0	46	19	.	.	.
cord-256217-fnjer0e0	47	1	In	in	IN
cord-256217-fnjer0e0	47	2	IPAF	IPAF	NNP
cord-256217-fnjer0e0	47	3	,	,	,
cord-256217-fnjer0e0	47	4	the	the	DT
cord-256217-fnjer0e0	47	5	immune	immune	JJ
cord-256217-fnjer0e0	47	6	reaction	reaction	NN
cord-256217-fnjer0e0	47	7	plays	play	VBZ
cord-256217-fnjer0e0	47	8	a	a	DT
cord-256217-fnjer0e0	47	9	primary	primary	JJ
cord-256217-fnjer0e0	47	10	role	role	NN
cord-256217-fnjer0e0	47	11	in	in	IN
cord-256217-fnjer0e0	47	12	its	-PRON-	PRP$
cord-256217-fnjer0e0	47	13	pathogenesis	pathogenesis	NN
cord-256217-fnjer0e0	47	14	.	.	.
cord-256217-fnjer0e0	48	1	However	however	RB
cord-256217-fnjer0e0	48	2	,	,	,
cord-256217-fnjer0e0	48	3	there	there	EX
cord-256217-fnjer0e0	48	4	is	be	VBZ
cord-256217-fnjer0e0	48	5	no	no	DT
cord-256217-fnjer0e0	48	6	general	general	JJ
cord-256217-fnjer0e0	48	7	agreement	agreement	NN
cord-256217-fnjer0e0	48	8	on	on	IN
cord-256217-fnjer0e0	48	9	any	any	DT
cord-256217-fnjer0e0	48	10	recommendations	recommendation	NNS
cord-256217-fnjer0e0	48	11	;	;	:
cord-256217-fnjer0e0	48	12	therefore	therefore	RB
cord-256217-fnjer0e0	48	13	,	,	,
cord-256217-fnjer0e0	48	14	even	even	RB
cord-256217-fnjer0e0	48	15	the	the	DT
cord-256217-fnjer0e0	48	16	diagnosis	diagnosis	NN
cord-256217-fnjer0e0	48	17	and	and	CC
cord-256217-fnjer0e0	48	18	management	management	NN
cord-256217-fnjer0e0	48	19	are	be	VBP
cord-256217-fnjer0e0	48	20	left	leave	VBN
cord-256217-fnjer0e0	48	21	to	to	IN
cord-256217-fnjer0e0	48	22	the	the	DT
cord-256217-fnjer0e0	48	23	individual	individual	JJ
cord-256217-fnjer0e0	48	24	caregiver	caregiver	NN
cord-256217-fnjer0e0	48	25	[	[	-LRB-
cord-256217-fnjer0e0	48	26	13	13	CD
cord-256217-fnjer0e0	48	27	]	]	-RRB-
cord-256217-fnjer0e0	48	28	.	.	.
cord-256217-fnjer0e0	49	1	While	while	IN
cord-256217-fnjer0e0	49	2	the	the	DT
cord-256217-fnjer0e0	49	3	use	use	NN
cord-256217-fnjer0e0	49	4	of	of	IN
cord-256217-fnjer0e0	49	5	anti	anti	JJ
cord-256217-fnjer0e0	49	6	-	-	JJ
cord-256217-fnjer0e0	49	7	TNF	tnf	NN
cord-256217-fnjer0e0	49	8	-	-	HYPH
cord-256217-fnjer0e0	49	9	alpha	alpha	NN
cord-256217-fnjer0e0	49	10	appears	appear	VBZ
cord-256217-fnjer0e0	49	11	quite	quite	RB
cord-256217-fnjer0e0	49	12	risky	risky	JJ
cord-256217-fnjer0e0	49	13	due	due	IN
cord-256217-fnjer0e0	49	14	to	to	IN
cord-256217-fnjer0e0	49	15	the	the	DT
cord-256217-fnjer0e0	49	16	possible	possible	JJ
cord-256217-fnjer0e0	49	17	occurrence	occurrence	NN
cord-256217-fnjer0e0	49	18	of	of	IN
cord-256217-fnjer0e0	49	19	fulminant	fulminant	JJ
cord-256217-fnjer0e0	49	20	tuberculosis	tuberculosis	NN
cord-256217-fnjer0e0	49	21	or	or	CC
cord-256217-fnjer0e0	49	22	might	may	MD
cord-256217-fnjer0e0	49	23	play	play	VB
cord-256217-fnjer0e0	49	24	a	a	DT
cord-256217-fnjer0e0	49	25	very	very	RB
cord-256217-fnjer0e0	49	26	limited	limited	JJ
cord-256217-fnjer0e0	49	27	role	role	NN
cord-256217-fnjer0e0	49	28	,	,	,
cord-256217-fnjer0e0	49	29	other	other	JJ
cord-256217-fnjer0e0	49	30	new	new	JJ
cord-256217-fnjer0e0	49	31	generation	generation	NN
cord-256217-fnjer0e0	49	32	immunosuppressives	immunosuppressive	NNS
cord-256217-fnjer0e0	49	33	,	,	,
cord-256217-fnjer0e0	49	34	such	such	JJ
cord-256217-fnjer0e0	49	35	as	as	IN
cord-256217-fnjer0e0	49	36	intravenous	intravenous	JJ
cord-256217-fnjer0e0	49	37	immunoglobulin	immunoglobulin	NN
cord-256217-fnjer0e0	49	38	,	,	,
cord-256217-fnjer0e0	49	39	selective	selective	JJ
cord-256217-fnjer0e0	49	40	IL-1	IL-1	NNP
cord-256217-fnjer0e0	49	41	cytokine	cytokine	NN
cord-256217-fnjer0e0	49	42	blockade	blockade	NN
cord-256217-fnjer0e0	49	43	,	,	,
cord-256217-fnjer0e0	49	44	and	and	CC
cord-256217-fnjer0e0	49	45	JAK	JAK	NNP
cord-256217-fnjer0e0	49	46	inhibition	inhibition	NN
cord-256217-fnjer0e0	49	47	[	[	-LRB-
cord-256217-fnjer0e0	49	48	6	6	CD
cord-256217-fnjer0e0	49	49	]	]	-RRB-
cord-256217-fnjer0e0	49	50	,	,	,
cord-256217-fnjer0e0	49	51	were	be	VBD
cord-256217-fnjer0e0	49	52	proposed	propose	VBN
cord-256217-fnjer0e0	49	53	.	.	.
cord-256217-fnjer0e0	50	1	However	however	RB
cord-256217-fnjer0e0	50	2	,	,	,
cord-256217-fnjer0e0	50	3	it	-PRON-	PRP
cord-256217-fnjer0e0	50	4	is	be	VBZ
cord-256217-fnjer0e0	50	5	unclear	unclear	JJ
cord-256217-fnjer0e0	50	6	why	why	WRB
cord-256217-fnjer0e0	50	7	the	the	DT
cord-256217-fnjer0e0	50	8	scientific	scientific	JJ
cord-256217-fnjer0e0	50	9	world	world	NN
cord-256217-fnjer0e0	50	10	is	be	VBZ
cord-256217-fnjer0e0	50	11	still	still	RB
cord-256217-fnjer0e0	50	12	strongly	strongly	RB
cord-256217-fnjer0e0	50	13	reluctant	reluctant	JJ
cord-256217-fnjer0e0	50	14	to	to	TO
cord-256217-fnjer0e0	50	15	promptly	promptly	RB
cord-256217-fnjer0e0	50	16	use	use	VB
cord-256217-fnjer0e0	50	17	steroids	steroid	NNS
cord-256217-fnjer0e0	50	18	to	to	TO
cord-256217-fnjer0e0	50	19	target	target	VB
cord-256217-fnjer0e0	50	20	the	the	DT
cord-256217-fnjer0e0	50	21	second	second	JJ
cord-256217-fnjer0e0	50	22	phase	phase	NN
cord-256217-fnjer0e0	50	23	of	of	IN
cord-256217-fnjer0e0	50	24	the	the	DT
cord-256217-fnjer0e0	50	25	disease	disease	NN
cord-256217-fnjer0e0	50	26	,	,	,
cord-256217-fnjer0e0	50	27	while	while	IN
cord-256217-fnjer0e0	50	28	this	this	DT
cord-256217-fnjer0e0	50	29	is	be	VBZ
cord-256217-fnjer0e0	50	30	not	not	RB
cord-256217-fnjer0e0	50	31	the	the	DT
cord-256217-fnjer0e0	50	32	case	case	NN
cord-256217-fnjer0e0	50	33	for	for	IN
cord-256217-fnjer0e0	50	34	monoclonals	monoclonal	NNS
cord-256217-fnjer0e0	50	35	.	.	.
cord-256217-fnjer0e0	51	1	Similarly	similarly	RB
cord-256217-fnjer0e0	51	2	to	to	IN
cord-256217-fnjer0e0	51	3	Ebola	Ebola	NNP
cord-256217-fnjer0e0	51	4	Virus	Virus	NNP
cord-256217-fnjer0e0	51	5	Disease	Disease	NNP
cord-256217-fnjer0e0	51	6	(	(	-LRB-
cord-256217-fnjer0e0	51	7	EVD	EVD	NNP
cord-256217-fnjer0e0	51	8	)	)	-RRB-
cord-256217-fnjer0e0	51	9	,	,	,
cord-256217-fnjer0e0	51	10	where	where	WRB
cord-256217-fnjer0e0	51	11	steroids	steroid	NNS
cord-256217-fnjer0e0	51	12	were	be	VBD
cord-256217-fnjer0e0	51	13	successfully	successfully	RB
cord-256217-fnjer0e0	51	14	used	use	VBN
cord-256217-fnjer0e0	51	15	even	even	RB
cord-256217-fnjer0e0	51	16	though	though	IN
cord-256217-fnjer0e0	51	17	empirically	empirically	RB
cord-256217-fnjer0e0	51	18	,	,	,
cord-256217-fnjer0e0	51	19	the	the	DT
cord-256217-fnjer0e0	51	20	number	number	NN
cord-256217-fnjer0e0	51	21	of	of	IN
cord-256217-fnjer0e0	51	22	circulating	circulate	VBG
cord-256217-fnjer0e0	51	23	T	t	NN
cord-256217-fnjer0e0	51	24	lymphocytes	lymphocyte	NNS
cord-256217-fnjer0e0	51	25	is	be	VBZ
cord-256217-fnjer0e0	51	26	dramatically	dramatically	RB
cord-256217-fnjer0e0	51	27	reduced	reduce	VBN
cord-256217-fnjer0e0	51	28	in	in	IN
cord-256217-fnjer0e0	51	29	severe	severe	JJ
cord-256217-fnjer0e0	51	30	cases	case	NNS
cord-256217-fnjer0e0	51	31	,	,	,
cord-256217-fnjer0e0	51	32	and	and	CC
cord-256217-fnjer0e0	51	33	elevated	elevated	JJ
cord-256217-fnjer0e0	51	34	cytokine	cytokine	NN
cord-256217-fnjer0e0	51	35	levels	level	NNS
cord-256217-fnjer0e0	51	36	in	in	IN
cord-256217-fnjer0e0	51	37	the	the	DT
cord-256217-fnjer0e0	51	38	serum	serum	NN
cord-256217-fnjer0e0	51	39	are	be	VBP
cord-256217-fnjer0e0	51	40	observed	observe	VBN
cord-256217-fnjer0e0	51	41	[	[	-LRB-
cord-256217-fnjer0e0	51	42	14	14	CD
cord-256217-fnjer0e0	51	43	]	]	-RRB-
cord-256217-fnjer0e0	51	44	.	.	.
cord-256217-fnjer0e0	52	1	Under	under	IN
cord-256217-fnjer0e0	52	2	that	that	DT
cord-256217-fnjer0e0	52	3	light	light	NN
cord-256217-fnjer0e0	52	4	,	,	,
cord-256217-fnjer0e0	52	5	steroids	steroid	NNS
cord-256217-fnjer0e0	52	6	might	may	MD
cord-256217-fnjer0e0	52	7	appear	appear	VB
cord-256217-fnjer0e0	52	8	a	a	DT
cord-256217-fnjer0e0	52	9	potent	potent	JJ
cord-256217-fnjer0e0	52	10	weapon	weapon	NN
cord-256217-fnjer0e0	52	11	against	against	IN
cord-256217-fnjer0e0	52	12	fatal	fatal	JJ
cord-256217-fnjer0e0	52	13	immune	immune	JJ
cord-256217-fnjer0e0	52	14	system	system	NN
cord-256217-fnjer0e0	52	15	activation	activation	NN
cord-256217-fnjer0e0	52	16	.	.	.
cord-256217-fnjer0e0	53	1	Since	since	IN
cord-256217-fnjer0e0	53	2	World	World	NNP
cord-256217-fnjer0e0	53	3	Health	Health	NNP
cord-256217-fnjer0e0	53	4	Organization	Organization	NNP
cord-256217-fnjer0e0	53	5	provided	provide	VBD
cord-256217-fnjer0e0	53	6	no	no	DT
cord-256217-fnjer0e0	53	7	guideline	guideline	NN
cord-256217-fnjer0e0	53	8	on	on	IN
cord-256217-fnjer0e0	53	9	corticosteroids	corticosteroid	NNS
cord-256217-fnjer0e0	53	10	use	use	VBP
cord-256217-fnjer0e0	53	11	for	for	IN
cord-256217-fnjer0e0	53	12	the	the	DT
cord-256217-fnjer0e0	53	13	management	management	NN
cord-256217-fnjer0e0	53	14	of	of	IN
cord-256217-fnjer0e0	53	15	SARS	SARS	NNP
cord-256217-fnjer0e0	53	16	-	-	HYPH
cord-256217-fnjer0e0	53	17	COV-2	COV-2	NNP
cord-256217-fnjer0e0	53	18	,	,	,
cord-256217-fnjer0e0	53	19	they	-PRON-	PRP
cord-256217-fnjer0e0	53	20	can	can	MD
cord-256217-fnjer0e0	53	21	be	be	VB
cord-256217-fnjer0e0	53	22	only	only	RB
cord-256217-fnjer0e0	53	23	used	use	VBN
cord-256217-fnjer0e0	53	24	empirically	empirically	RB
cord-256217-fnjer0e0	53	25	with	with	IN
cord-256217-fnjer0e0	53	26	no	no	DT
cord-256217-fnjer0e0	53	27	indication	indication	NN
cord-256217-fnjer0e0	53	28	on	on	IN
cord-256217-fnjer0e0	53	29	timing	timing	NN
cord-256217-fnjer0e0	53	30	,	,	,
cord-256217-fnjer0e0	53	31	duration	duration	NN
cord-256217-fnjer0e0	53	32	,	,	,
cord-256217-fnjer0e0	53	33	and	and	CC
cord-256217-fnjer0e0	53	34	dosage	dosage	NN
cord-256217-fnjer0e0	53	35	.	.	.
cord-256217-fnjer0e0	54	1	In	in	IN
cord-256217-fnjer0e0	54	2	addition	addition	NN
cord-256217-fnjer0e0	54	3	,	,	,
cord-256217-fnjer0e0	54	4	early	early	JJ
cord-256217-fnjer0e0	54	5	use	use	NN
cord-256217-fnjer0e0	54	6	of	of	IN
cord-256217-fnjer0e0	54	7	steroids	steroid	NNS
cord-256217-fnjer0e0	54	8	seems	seem	VBZ
cord-256217-fnjer0e0	54	9	to	to	TO
cord-256217-fnjer0e0	54	10	exert	exert	VB
cord-256217-fnjer0e0	54	11	a	a	DT
cord-256217-fnjer0e0	54	12	more	more	RBR
cord-256217-fnjer0e0	54	13	than	than	IN
cord-256217-fnjer0e0	54	14	promising	promising	JJ
cord-256217-fnjer0e0	54	15	control	control	NN
cord-256217-fnjer0e0	54	16	of	of	IN
cord-256217-fnjer0e0	54	17	inflammatory	inflammatory	JJ
cord-256217-fnjer0e0	54	18	response	response	NN
cord-256217-fnjer0e0	54	19	in	in	IN
cord-256217-fnjer0e0	54	20	other	other	JJ
cord-256217-fnjer0e0	54	21	severe	severe	JJ
cord-256217-fnjer0e0	54	22	viral	viral	JJ
cord-256217-fnjer0e0	54	23	diseases	disease	NNS
cord-256217-fnjer0e0	54	24	[	[	-LRB-
cord-256217-fnjer0e0	54	25	14	14	CD
cord-256217-fnjer0e0	54	26	]	]	-RRB-
cord-256217-fnjer0e0	54	27	.	.	.
cord-256217-fnjer0e0	55	1	The	the	DT
cord-256217-fnjer0e0	55	2	same	same	JJ
cord-256217-fnjer0e0	55	3	issue	issue	NN
cord-256217-fnjer0e0	55	4	was	be	VBD
cord-256217-fnjer0e0	55	5	addressed	address	VBN
cord-256217-fnjer0e0	55	6	several	several	JJ
cord-256217-fnjer0e0	55	7	times	time	NNS
cord-256217-fnjer0e0	55	8	for	for	IN
cord-256217-fnjer0e0	55	9	more	more	JJR
cord-256217-fnjer0e0	55	10	common	common	JJ
cord-256217-fnjer0e0	55	11	diseases	disease	NNS
cord-256217-fnjer0e0	55	12	like	like	IN
cord-256217-fnjer0e0	55	13	herpes	herpes	NN
cord-256217-fnjer0e0	55	14	virus	virus	NN
cord-256217-fnjer0e0	55	15	encephalitis	encephalitis	JJ
cord-256217-fnjer0e0	55	16	[	[	-LRB-
cord-256217-fnjer0e0	55	17	15	15	CD
cord-256217-fnjer0e0	55	18	]	]	-RRB-
cord-256217-fnjer0e0	55	19	,	,	,
cord-256217-fnjer0e0	55	20	which	which	WDT
cord-256217-fnjer0e0	55	21	is	be	VBZ
cord-256217-fnjer0e0	55	22	universally	universally	RB
cord-256217-fnjer0e0	55	23	recognized	recognize	VBN
cord-256217-fnjer0e0	55	24	as	as	IN
cord-256217-fnjer0e0	55	25	a	a	DT
cord-256217-fnjer0e0	55	26	postviral	postviral	JJ
cord-256217-fnjer0e0	55	27	autoimmune	autoimmune	JJ
cord-256217-fnjer0e0	55	28	response	response	NN
cord-256217-fnjer0e0	55	29	.	.	.
cord-256217-fnjer0e0	56	1	Herpetic	herpetic	JJ
cord-256217-fnjer0e0	56	2	postviral	postviral	NN
cord-256217-fnjer0e0	56	3	central	central	JJ
cord-256217-fnjer0e0	56	4	nervous	nervous	JJ
cord-256217-fnjer0e0	56	5	system	system	NN
cord-256217-fnjer0e0	56	6	inflammation	inflammation	NN
cord-256217-fnjer0e0	56	7	has	have	VBZ
cord-256217-fnjer0e0	56	8	corticosteroids	corticosteroid	NNS
cord-256217-fnjer0e0	56	9	as	as	IN
cord-256217-fnjer0e0	56	10	the	the	DT
cord-256217-fnjer0e0	56	11	first	first	JJ
cord-256217-fnjer0e0	56	12	line	line	NN
cord-256217-fnjer0e0	56	13	drug	drug	NN
cord-256217-fnjer0e0	56	14	in	in	IN
cord-256217-fnjer0e0	56	15	the	the	DT
cord-256217-fnjer0e0	56	16	therapeutic	therapeutic	JJ
cord-256217-fnjer0e0	56	17	armamentarium	armamentarium	NN
cord-256217-fnjer0e0	56	18	[	[	-LRB-
cord-256217-fnjer0e0	56	19	16	16	CD
cord-256217-fnjer0e0	56	20	]	]	-RRB-
cord-256217-fnjer0e0	56	21	and	and	CC
cord-256217-fnjer0e0	56	22	might	may	MD
cord-256217-fnjer0e0	56	23	be	be	VB
cord-256217-fnjer0e0	56	24	considered	consider	VBN
cord-256217-fnjer0e0	56	25	a	a	DT
cord-256217-fnjer0e0	56	26	possible	possible	JJ
cord-256217-fnjer0e0	56	27	model	model	NN
cord-256217-fnjer0e0	56	28	for	for	IN
cord-256217-fnjer0e0	56	29	a	a	DT
cord-256217-fnjer0e0	56	30	prompt	prompt	JJ
cord-256217-fnjer0e0	56	31	response	response	NN
cord-256217-fnjer0e0	56	32	in	in	IN
cord-256217-fnjer0e0	56	33	treating	treat	VBG
cord-256217-fnjer0e0	56	34	earlier	early	JJR
cord-256217-fnjer0e0	56	35	life	life	NN
cord-256217-fnjer0e0	56	36	-	-	HYPH
cord-256217-fnjer0e0	56	37	threatening	threaten	VBG
cord-256217-fnjer0e0	56	38	forms	form	NNS
cord-256217-fnjer0e0	56	39	of	of	IN
cord-256217-fnjer0e0	56	40	SARS	SARS	NNP
cord-256217-fnjer0e0	56	41	-	-	HYPH
cord-256217-fnjer0e0	56	42	COV-2	COV-2	NNP
cord-256217-fnjer0e0	56	43	.	.	.
cord-256217-fnjer0e0	57	1	On	on	IN
cord-256217-fnjer0e0	57	2	the	the	DT
cord-256217-fnjer0e0	57	3	basis	basis	NN
cord-256217-fnjer0e0	57	4	of	of	IN
cord-256217-fnjer0e0	57	5	the	the	DT
cord-256217-fnjer0e0	57	6	current	current	JJ
cord-256217-fnjer0e0	57	7	knowledge	knowledge	NN
cord-256217-fnjer0e0	57	8	,	,	,
cord-256217-fnjer0e0	57	9	corticosteroids	corticosteroid	NNS
cord-256217-fnjer0e0	57	10	might	may	MD
cord-256217-fnjer0e0	57	11	be	be	VB
cord-256217-fnjer0e0	57	12	a	a	DT
cord-256217-fnjer0e0	57	13	potent	potent	JJ
cord-256217-fnjer0e0	57	14	therapeutic	therapeutic	JJ
cord-256217-fnjer0e0	57	15	weapon	weapon	NN
cord-256217-fnjer0e0	57	16	for	for	IN
cord-256217-fnjer0e0	57	17	the	the	DT
cord-256217-fnjer0e0	57	18	second	second	JJ
cord-256217-fnjer0e0	57	19	phase	phase	NN
cord-256217-fnjer0e0	57	20	of	of	IN
cord-256217-fnjer0e0	57	21	the	the	DT
cord-256217-fnjer0e0	57	22	disease	disease	NN
cord-256217-fnjer0e0	57	23	,	,	,
cord-256217-fnjer0e0	57	24	when	when	WRB
cord-256217-fnjer0e0	57	25	the	the	DT
cord-256217-fnjer0e0	57	26	immune	immune	JJ
cord-256217-fnjer0e0	57	27	system	system	NN
cord-256217-fnjer0e0	57	28	targets	target	VBZ
cord-256217-fnjer0e0	57	29	dramatically	dramatically	RB
cord-256217-fnjer0e0	57	30	multiple	multiple	JJ
cord-256217-fnjer0e0	57	31	organs	organ	NNS
cord-256217-fnjer0e0	57	32	and	and	CC
cord-256217-fnjer0e0	57	33	specifically	specifically	RB
cord-256217-fnjer0e0	57	34	the	the	DT
cord-256217-fnjer0e0	57	35	lungs	lung	NNS
cord-256217-fnjer0e0	57	36	,	,	,
cord-256217-fnjer0e0	57	37	while	while	IN
cord-256217-fnjer0e0	57	38	it	-PRON-	PRP
cord-256217-fnjer0e0	57	39	has	have	VBZ
cord-256217-fnjer0e0	57	40	to	to	TO
cord-256217-fnjer0e0	57	41	be	be	VB
cord-256217-fnjer0e0	57	42	kept	keep	VBN
cord-256217-fnjer0e0	57	43	in	in	IN
cord-256217-fnjer0e0	57	44	mind	mind	NN
cord-256217-fnjer0e0	57	45	that	that	IN
cord-256217-fnjer0e0	57	46	their	-PRON-	PRP$
cord-256217-fnjer0e0	57	47	use	use	NN
cord-256217-fnjer0e0	57	48	can	can	MD
cord-256217-fnjer0e0	57	49	be	be	VB
cord-256217-fnjer0e0	57	50	risky	risky	JJ
cord-256217-fnjer0e0	57	51	when	when	WRB
cord-256217-fnjer0e0	57	52	the	the	DT
cord-256217-fnjer0e0	57	53	activation	activation	NN
cord-256217-fnjer0e0	57	54	of	of	IN
cord-256217-fnjer0e0	57	55	inflammatory	inflammatory	JJ
cord-256217-fnjer0e0	57	56	processes	process	NNS
cord-256217-fnjer0e0	57	57	remains	remain	VBZ
cord-256217-fnjer0e0	57	58	within	within	IN
cord-256217-fnjer0e0	57	59	the	the	DT
cord-256217-fnjer0e0	57	60	normal	normal	JJ
cord-256217-fnjer0e0	57	61	range	range	NN
cord-256217-fnjer0e0	57	62	.	.	.
cord-256217-fnjer0e0	58	1	However	however	RB
cord-256217-fnjer0e0	58	2	,	,	,
cord-256217-fnjer0e0	58	3	the	the	DT
cord-256217-fnjer0e0	58	4	risk	risk	NN
cord-256217-fnjer0e0	58	5	/	/	SYM
cord-256217-fnjer0e0	58	6	benefit	benefit	NN
cord-256217-fnjer0e0	58	7	ratio	ratio	NN
cord-256217-fnjer0e0	58	8	of	of	IN
cord-256217-fnjer0e0	58	9	corticosteroids	corticosteroid	NNS
cord-256217-fnjer0e0	58	10	for	for	IN
cord-256217-fnjer0e0	58	11	severe	severe	JJ
cord-256217-fnjer0e0	58	12	form	form	NN
cord-256217-fnjer0e0	58	13	of	of	IN
cord-256217-fnjer0e0	58	14	SARS	SARS	NNP
cord-256217-fnjer0e0	58	15	-	-	HYPH
cord-256217-fnjer0e0	58	16	COV-2	COV-2	NNP
cord-256217-fnjer0e0	58	17	disease	disease	NN
cord-256217-fnjer0e0	58	18	should	should	MD
cord-256217-fnjer0e0	58	19	be	be	VB
cord-256217-fnjer0e0	58	20	clarified	clarify	VBN
cord-256217-fnjer0e0	58	21	by	by	IN
cord-256217-fnjer0e0	58	22	the	the	DT
cord-256217-fnjer0e0	58	23	health	health	NN
cord-256217-fnjer0e0	58	24	authorities	authority	NNS
cord-256217-fnjer0e0	58	25	[	[	-LRB-
cord-256217-fnjer0e0	58	26	17	17	CD
cord-256217-fnjer0e0	58	27	]	]	-RRB-
cord-256217-fnjer0e0	58	28	,	,	,
cord-256217-fnjer0e0	58	29	as	as	RB
cord-256217-fnjer0e0	58	30	well	well	RB
cord-256217-fnjer0e0	58	31	as	as	IN
cord-256217-fnjer0e0	58	32	the	the	DT
cord-256217-fnjer0e0	58	33	weight	weight	NN
cord-256217-fnjer0e0	58	34	of	of	IN
cord-256217-fnjer0e0	58	35	cost	cost	NN
cord-256217-fnjer0e0	58	36	-	-	HYPH
cord-256217-fnjer0e0	58	37	effectiveness	effectiveness	NN
cord-256217-fnjer0e0	58	38	compared	compare	VBN
cord-256217-fnjer0e0	58	39	to	to	IN
cord-256217-fnjer0e0	58	40	other	other	JJ
cord-256217-fnjer0e0	58	41	therapies	therapy	NNS
cord-256217-fnjer0e0	58	42	like	like	IN
cord-256217-fnjer0e0	58	43	monoclonals	monoclonal	NNS
cord-256217-fnjer0e0	58	44	.	.	.
cord-256217-fnjer0e0	59	1	Moreover	moreover	RB
cord-256217-fnjer0e0	59	2	,	,	,
cord-256217-fnjer0e0	59	3	the	the	DT
cord-256217-fnjer0e0	59	4	SARS	SARS	NNP
cord-256217-fnjer0e0	59	5	-	-	HYPH
cord-256217-fnjer0e0	59	6	COV-2	COV-2	NNP
cord-256217-fnjer0e0	59	7	pneumonia	pneumonia	NN
cord-256217-fnjer0e0	59	8	animal	animal	NN
cord-256217-fnjer0e0	59	9	model	model	NN
cord-256217-fnjer0e0	59	10	described	describe	VBN
cord-256217-fnjer0e0	59	11	in	in	IN
cord-256217-fnjer0e0	59	12	2010	2010	CD
cord-256217-fnjer0e0	59	13	by	by	IN
cord-256217-fnjer0e0	59	14	Smits	Smits	NNP
cord-256217-fnjer0e0	59	15	et	et	NNP
cord-256217-fnjer0e0	59	16	al	al	NNP
cord-256217-fnjer0e0	59	17	.	.	.
cord-256217-fnjer0e0	60	1	[	[	-LRB-
cord-256217-fnjer0e0	60	2	18	18	CD
cord-256217-fnjer0e0	60	3	]	]	-RRB-
cord-256217-fnjer0e0	60	4	presents	present	VBZ
cord-256217-fnjer0e0	60	5	many	many	JJ
cord-256217-fnjer0e0	60	6	similarities	similarity	NNS
cord-256217-fnjer0e0	60	7	with	with	IN
cord-256217-fnjer0e0	60	8	ECOR	ECOR	NNP
cord-256217-fnjer0e0	60	9	reported	report	VBD
cord-256217-fnjer0e0	60	10	almost	almost	RB
cord-256217-fnjer0e0	60	11	2	2	CD
cord-256217-fnjer0e0	60	12	decades	decade	NNS
cord-256217-fnjer0e0	60	13	earlier	early	RBR
cord-256217-fnjer0e0	60	14	,	,	,
cord-256217-fnjer0e0	60	15	in	in	IN
cord-256217-fnjer0e0	60	16	terms	term	NNS
cord-256217-fnjer0e0	60	17	of	of	IN
cord-256217-fnjer0e0	60	18	viral	viral	JJ
cord-256217-fnjer0e0	60	19	clearance	clearance	NN
cord-256217-fnjer0e0	60	20	and	and	CC
cord-256217-fnjer0e0	60	21	timing	timing	NN
cord-256217-fnjer0e0	60	22	of	of	IN
cord-256217-fnjer0e0	60	23	immune	immune	JJ
cord-256217-fnjer0e0	60	24	response	response	NN
cord-256217-fnjer0e0	60	25	.	.	.
cord-256217-fnjer0e0	61	1	Considering	consider	VBG
cord-256217-fnjer0e0	61	2	the	the	DT
cord-256217-fnjer0e0	61	3	course	course	NN
cord-256217-fnjer0e0	61	4	of	of	IN
cord-256217-fnjer0e0	61	5	the	the	DT
cord-256217-fnjer0e0	61	6	disease	disease	NN
cord-256217-fnjer0e0	61	7	,	,	,
cord-256217-fnjer0e0	61	8	it	-PRON-	PRP
cord-256217-fnjer0e0	61	9	seems	seem	VBZ
cord-256217-fnjer0e0	61	10	the	the	DT
cord-256217-fnjer0e0	61	11	supposed	suppose	VBN
cord-256217-fnjer0e0	61	12	postcoronavirus	postcoronavirus	NNP
cord-256217-fnjer0e0	61	13	immune	immune	NNP
cord-256217-fnjer0e0	61	14	response	response	NN
cord-256217-fnjer0e0	61	15	happens	happen	VBZ
cord-256217-fnjer0e0	61	16	within	within	IN
cord-256217-fnjer0e0	61	17	10	10	CD
cord-256217-fnjer0e0	61	18	to	to	TO
cord-256217-fnjer0e0	61	19	14	14	CD
cord-256217-fnjer0e0	61	20	days	day	NNS
cord-256217-fnjer0e0	61	21	after	after	IN
cord-256217-fnjer0e0	61	22	the	the	DT
cord-256217-fnjer0e0	61	23	onset	onset	NN
cord-256217-fnjer0e0	61	24	of	of	IN
cord-256217-fnjer0e0	61	25	the	the	DT
cord-256217-fnjer0e0	61	26	disease	disease	NN
cord-256217-fnjer0e0	61	27	in	in	IN
cord-256217-fnjer0e0	61	28	both	both	DT
cord-256217-fnjer0e0	61	29	models	model	NNS
cord-256217-fnjer0e0	61	30	.	.	.
cord-256217-fnjer0e0	62	1	Consequently	consequently	RB
cord-256217-fnjer0e0	62	2	,	,	,
cord-256217-fnjer0e0	62	3	that	that	DT
cord-256217-fnjer0e0	62	4	might	may	MD
cord-256217-fnjer0e0	62	5	be	be	VB
cord-256217-fnjer0e0	62	6	the	the	DT
cord-256217-fnjer0e0	62	7	appropriate	appropriate	JJ
cord-256217-fnjer0e0	62	8	timing	timing	NN
cord-256217-fnjer0e0	62	9	to	to	TO
cord-256217-fnjer0e0	62	10	treat	treat	VB
cord-256217-fnjer0e0	62	11	,	,	,
cord-256217-fnjer0e0	62	12	while	while	IN
cord-256217-fnjer0e0	62	13	the	the	DT
cord-256217-fnjer0e0	62	14	viral	viral	JJ
cord-256217-fnjer0e0	62	15	insult	insult	NN
cord-256217-fnjer0e0	62	16	might	may	MD
cord-256217-fnjer0e0	62	17	be	be	VB
cord-256217-fnjer0e0	62	18	over	over	RB
cord-256217-fnjer0e0	62	19	already	already	RB
cord-256217-fnjer0e0	62	20	as	as	IN
cord-256217-fnjer0e0	62	21	per	per	IN
cord-256217-fnjer0e0	62	22	the	the	DT
cord-256217-fnjer0e0	62	23	animal	animal	NN
cord-256217-fnjer0e0	62	24	model	model	NN
cord-256217-fnjer0e0	62	25	.	.	.
cord-256217-fnjer0e0	63	1	At	at	IN
cord-256217-fnjer0e0	63	2	that	that	DT
cord-256217-fnjer0e0	63	3	time	time	NN
cord-256217-fnjer0e0	63	4	,	,	,
cord-256217-fnjer0e0	63	5	a	a	DT
cord-256217-fnjer0e0	63	6	prompt	prompt	JJ
cord-256217-fnjer0e0	63	7	intervention	intervention	NN
cord-256217-fnjer0e0	63	8	with	with	IN
cord-256217-fnjer0e0	63	9	no	no	DT
cord-256217-fnjer0e0	63	10	delay	delay	NN
cord-256217-fnjer0e0	63	11	either	either	CC
cord-256217-fnjer0e0	63	12	by	by	IN
cord-256217-fnjer0e0	63	13	monoclonals	monoclonal	NNS
cord-256217-fnjer0e0	63	14	or	or	CC
cord-256217-fnjer0e0	63	15	by	by	IN
cord-256217-fnjer0e0	63	16	steroids	steroid	NNS
cord-256217-fnjer0e0	63	17	may	may	MD
cord-256217-fnjer0e0	63	18	rescue	rescue	VB
cord-256217-fnjer0e0	63	19	the	the	DT
cord-256217-fnjer0e0	63	20	patient	patient	NN
cord-256217-fnjer0e0	63	21	and	and	CC
cord-256217-fnjer0e0	63	22	avoid	avoid	VB
cord-256217-fnjer0e0	63	23	the	the	DT
cord-256217-fnjer0e0	63	24	local	local	JJ
cord-256217-fnjer0e0	63	25	immune	immune	NN
cord-256217-fnjer0e0	63	26	-	-	HYPH
cord-256217-fnjer0e0	63	27	driven	drive	VBN
cord-256217-fnjer0e0	63	28	irreversible	irreversible	JJ
cord-256217-fnjer0e0	63	29	tissue	tissue	NN
cord-256217-fnjer0e0	63	30	damage	damage	NN
cord-256217-fnjer0e0	63	31	.	.	.
cord-256217-fnjer0e0	64	1	It	-PRON-	PRP
cord-256217-fnjer0e0	64	2	might	may	MD
cord-256217-fnjer0e0	64	3	have	have	VB
cord-256217-fnjer0e0	64	4	been	be	VBN
cord-256217-fnjer0e0	64	5	appropriate	appropriate	JJ
cord-256217-fnjer0e0	64	6	to	to	TO
cord-256217-fnjer0e0	64	7	test	test	VB
cord-256217-fnjer0e0	64	8	these	these	DT
cord-256217-fnjer0e0	64	9	hypotheses	hypothesis	NNS
cord-256217-fnjer0e0	64	10	by	by	IN
cord-256217-fnjer0e0	64	11	an	an	DT
cord-256217-fnjer0e0	64	12	appropriate	appropriate	JJ
cord-256217-fnjer0e0	64	13	trial	trial	NN
cord-256217-fnjer0e0	64	14	,	,	,
cord-256217-fnjer0e0	64	15	but	but	CC
cord-256217-fnjer0e0	64	16	nowadays	nowadays	RB
cord-256217-fnjer0e0	64	17	time	time	NN
cord-256217-fnjer0e0	64	18	does	do	VBZ
cord-256217-fnjer0e0	64	19	not	not	RB
cord-256217-fnjer0e0	64	20	play	play	VB
cord-256217-fnjer0e0	64	21	in	in	IN
cord-256217-fnjer0e0	64	22	favor	favor	NN
cord-256217-fnjer0e0	65	1	and	and	CC
cord-256217-fnjer0e0	65	2	there	there	EX
cord-256217-fnjer0e0	65	3	is	be	VBZ
cord-256217-fnjer0e0	65	4	the	the	DT
cord-256217-fnjer0e0	65	5	urgent	urgent	JJ
cord-256217-fnjer0e0	65	6	need	need	NN
cord-256217-fnjer0e0	65	7	of	of	IN
cord-256217-fnjer0e0	65	8	a	a	DT
cord-256217-fnjer0e0	65	9	prompt	prompt	JJ
cord-256217-fnjer0e0	65	10	and	and	CC
cord-256217-fnjer0e0	65	11	brave	brave	JJ
cord-256217-fnjer0e0	65	12	action	action	NN
cord-256217-fnjer0e0	65	13	.	.	.
cord-256217-fnjer0e0	66	1	Can	Can	MD
cord-256217-fnjer0e0	66	2	the	the	DT
cord-256217-fnjer0e0	66	3	coronavirus	coronavirus	NN
cord-256217-fnjer0e0	66	4	disease	disease	NN
cord-256217-fnjer0e0	66	5	2019	2019	CD
cord-256217-fnjer0e0	66	6	(	(	-LRB-
cord-256217-fnjer0e0	66	7	COVID-19	COVID-19	NNP
cord-256217-fnjer0e0	66	8	)	)	-RRB-
cord-256217-fnjer0e0	66	9	affect	affect	VB
cord-256217-fnjer0e0	66	10	the	the	DT
cord-256217-fnjer0e0	66	11	eyes	eye	NNS
cord-256217-fnjer0e0	66	12	?	?	.
cord-256217-fnjer0e0	67	1	A	a	DT
cord-256217-fnjer0e0	67	2	review	review	NN
cord-256217-fnjer0e0	67	3	of	of	IN
cord-256217-fnjer0e0	67	4	coronaviruses	coronaviruse	NNS
cord-256217-fnjer0e0	67	5	and	and	CC
cord-256217-fnjer0e0	67	6	ocular	ocular	JJ
cord-256217-fnjer0e0	67	7	implications	implication	NNS
cord-256217-fnjer0e0	67	8	in	in	IN
cord-256217-fnjer0e0	67	9	humans	human	NNS
cord-256217-fnjer0e0	67	10	and	and	CC
cord-256217-fnjer0e0	67	11	animals	animal	NNS
cord-256217-fnjer0e0	68	1	WHO	who	WP
cord-256217-fnjer0e0	68	2	(	(	-LRB-
cord-256217-fnjer0e0	68	3	2020	2020	CD
cord-256217-fnjer0e0	68	4	)	)	-RRB-
cord-256217-fnjer0e0	69	1	WHO	who	WP
cord-256217-fnjer0e0	69	2	director	director	NN
cord-256217-fnjer0e0	69	3	-	-	HYPH
cord-256217-fnjer0e0	69	4	general	general	NNP
cord-256217-fnjer0e0	69	5	's	's	POS
cord-256217-fnjer0e0	69	6	opening	opening	NN
cord-256217-fnjer0e0	69	7	remarks	remark	NNS
cord-256217-fnjer0e0	69	8	at	at	IN
cord-256217-fnjer0e0	69	9	the	the	DT
cord-256217-fnjer0e0	69	10	media	medium	NNS
cord-256217-fnjer0e0	69	11	briefing	briefing	NN
cord-256217-fnjer0e0	69	12	on	on	IN
cord-256217-fnjer0e0	69	13	COVID-19	COVID-19	NNP
cord-256217-fnjer0e0	69	14	-	-	HYPH
cord-256217-fnjer0e0	69	15	11	11	CD
cord-256217-fnjer0e0	69	16	WHO	WHO	NNP
cord-256217-fnjer0e0	69	17	(	(	-LRB-
cord-256217-fnjer0e0	69	18	2020	2020	CD
cord-256217-fnjer0e0	69	19	)	)	-RRB-
cord-256217-fnjer0e0	70	1	Coronavirus	Coronavirus	NNP
cord-256217-fnjer0e0	70	2	disease	disease	NN
cord-256217-fnjer0e0	70	3	2019	2019	CD
cord-256217-fnjer0e0	70	4	(	(	-LRB-
cord-256217-fnjer0e0	70	5	COVID-19	COVID-19	NNP
cord-256217-fnjer0e0	70	6	)	)	-RRB-
cord-256217-fnjer0e0	70	7	situation	situation	NN
cord-256217-fnjer0e0	70	8	report-81	report-81	NNP
cord-256217-fnjer0e0	70	9	Chloroquine	Chloroquine	NNP
cord-256217-fnjer0e0	70	10	and	and	CC
cord-256217-fnjer0e0	70	11	hydroxychloroquine	hydroxychloroquine	NN
cord-256217-fnjer0e0	70	12	as	as	IN
cord-256217-fnjer0e0	70	13	available	available	JJ
cord-256217-fnjer0e0	70	14	weapons	weapon	NNS
cord-256217-fnjer0e0	70	15	to	to	TO
cord-256217-fnjer0e0	70	16	fight	fight	VB
cord-256217-fnjer0e0	70	17	COVID-19	COVID-19	NNP
cord-256217-fnjer0e0	70	18	World	World	NNP
cord-256217-fnjer0e0	70	19	Health	Health	NNP
cord-256217-fnjer0e0	70	20	Organization	Organization	NNP
cord-256217-fnjer0e0	70	21	declares	declare	VBZ
cord-256217-fnjer0e0	70	22	global	global	JJ
cord-256217-fnjer0e0	70	23	emergency	emergency	NN
cord-256217-fnjer0e0	70	24	:	:	:
cord-256217-fnjer0e0	70	25	a	a	DT
cord-256217-fnjer0e0	70	26	review	review	NN
cord-256217-fnjer0e0	70	27	of	of	IN
cord-256217-fnjer0e0	70	28	the	the	DT
cord-256217-fnjer0e0	70	29	2019	2019	CD
cord-256217-fnjer0e0	70	30	novel	novel	NN
cord-256217-fnjer0e0	70	31	coronavirus	coronavirus	NN
cord-256217-fnjer0e0	70	32	(	(	-LRB-
cord-256217-fnjer0e0	70	33	COVID-19	COVID-19	NNP
cord-256217-fnjer0e0	70	34	)	)	-RRB-
cord-256217-fnjer0e0	70	35	HLH	HLH	NNP
cord-256217-fnjer0e0	70	36	across	across	IN
cord-256217-fnjer0e0	70	37	speciality	speciality	NN
cord-256217-fnjer0e0	70	38	collaboration	collaboration	NN
cord-256217-fnjer0e0	70	39	,	,	,
cord-256217-fnjer0e0	70	40	UK	UK	NNP
cord-256217-fnjer0e0	70	41	COVID-19	COVID-19	NNP
cord-256217-fnjer0e0	70	42	:	:	:
cord-256217-fnjer0e0	70	43	consider	consider	VB
cord-256217-fnjer0e0	70	44	cytokine	cytokine	JJ
cord-256217-fnjer0e0	70	45	storm	storm	NN
cord-256217-fnjer0e0	70	46	syndromes	syndrome	NNS
cord-256217-fnjer0e0	70	47	and	and	CC
cord-256217-fnjer0e0	70	48	immunosuppression	immunosuppression	NN
cord-256217-fnjer0e0	71	1	The	the	DT
cord-256217-fnjer0e0	71	2	cytokine	cytokine	NN
cord-256217-fnjer0e0	71	3	release	release	NN
cord-256217-fnjer0e0	71	4	syndrome	syndrome	NN
cord-256217-fnjer0e0	71	5	(	(	-LRB-
cord-256217-fnjer0e0	71	6	CRS	CRS	NNP
cord-256217-fnjer0e0	71	7	)	)	-RRB-
cord-256217-fnjer0e0	71	8	of	of	IN
cord-256217-fnjer0e0	71	9	severe	severe	JJ
cord-256217-fnjer0e0	71	10	COVID-19	covid-19	NN
cord-256217-fnjer0e0	71	11	and	and	CC
cord-256217-fnjer0e0	71	12	Interleukin-6	Interleukin-6	NNP
cord-256217-fnjer0e0	72	1	receptor	receptor	NN
cord-256217-fnjer0e0	72	2	(	(	-LRB-
cord-256217-fnjer0e0	72	3	IL-6R	IL-6R	NNP
cord-256217-fnjer0e0	72	4	)	)	-RRB-
cord-256217-fnjer0e0	72	5	antagonist	antagonist	NN
cord-256217-fnjer0e0	73	1	Tocilizumab	Tocilizumab	NNP
cord-256217-fnjer0e0	73	2	may	may	MD
cord-256217-fnjer0e0	73	3	be	be	VB
cord-256217-fnjer0e0	73	4	the	the	DT
cord-256217-fnjer0e0	73	5	key	key	NN
cord-256217-fnjer0e0	73	6	to	to	TO
cord-256217-fnjer0e0	73	7	reduce	reduce	VB
cord-256217-fnjer0e0	73	8	the	the	DT
cord-256217-fnjer0e0	73	9	mortality	mortality	NN
cord-256217-fnjer0e0	73	10	Retinopathy	retinopathy	NN
cord-256217-fnjer0e0	73	11	following	follow	VBG
cord-256217-fnjer0e0	73	12	intravitreal	intravitreal	NN
cord-256217-fnjer0e0	73	13	injection	injection	NN
cord-256217-fnjer0e0	73	14	of	of	IN
cord-256217-fnjer0e0	73	15	mice	mouse	NNS
cord-256217-fnjer0e0	73	16	with	with	IN
cord-256217-fnjer0e0	73	17	MHV	MHV	NNP
cord-256217-fnjer0e0	73	18	strain	strain	NN
cord-256217-fnjer0e0	73	19	JHM	JHM	NNP
cord-256217-fnjer0e0	73	20	Ocular	ocular	JJ
cord-256217-fnjer0e0	73	21	tropisms	tropism	NNS
cord-256217-fnjer0e0	73	22	of	of	IN
cord-256217-fnjer0e0	73	23	murine	murine	JJ
cord-256217-fnjer0e0	73	24	coronavirus	coronavirus	NN
cord-256217-fnjer0e0	73	25	(	(	-LRB-
cord-256217-fnjer0e0	73	26	strain	strain	NN
cord-256217-fnjer0e0	73	27	JHM	JHM	NNP
cord-256217-fnjer0e0	73	28	)	)	-RRB-
cord-256217-fnjer0e0	73	29	after	after	IN
cord-256217-fnjer0e0	73	30	inoculation	inoculation	NN
cord-256217-fnjer0e0	73	31	by	by	IN
cord-256217-fnjer0e0	73	32	various	various	JJ
cord-256217-fnjer0e0	73	33	routes	route	NNS
cord-256217-fnjer0e0	74	1	Guillain	Guillain	NNP
cord-256217-fnjer0e0	74	2	-	-	HYPH
cord-256217-fnjer0e0	74	3	Barré	Barré	NNP
cord-256217-fnjer0e0	74	4	syndrome	syndrome	NN
cord-256217-fnjer0e0	74	5	associated	associate	VBN
cord-256217-fnjer0e0	74	6	with	with	IN
cord-256217-fnjer0e0	74	7	SARS	SARS	NNP
cord-256217-fnjer0e0	74	8	-	-	HYPH
cord-256217-fnjer0e0	74	9	CoV-2	CoV-2	NNP
cord-256217-fnjer0e0	74	10	infection	infection	NN
cord-256217-fnjer0e0	74	11	:	:	:
cord-256217-fnjer0e0	74	12	causality	causality	NN
cord-256217-fnjer0e0	74	13	or	or	CC
cord-256217-fnjer0e0	74	14	coincidence	coincidence	NN
cord-256217-fnjer0e0	74	15	?	?	.
cord-256217-fnjer0e0	75	1	A	a	DT
cord-256217-fnjer0e0	75	2	pathological	pathological	JJ
cord-256217-fnjer0e0	75	3	report	report	NN
cord-256217-fnjer0e0	75	4	of	of	IN
cord-256217-fnjer0e0	75	5	three	three	CD
cord-256217-fnjer0e0	75	6	COVID-19	covid-19	CD
cord-256217-fnjer0e0	75	7	cases	case	NNS
cord-256217-fnjer0e0	75	8	by	by	IN
cord-256217-fnjer0e0	75	9	minimally	minimally	RB
cord-256217-fnjer0e0	75	10	invasive	invasive	JJ
cord-256217-fnjer0e0	75	11	autopsies	autopsy	NNS
cord-256217-fnjer0e0	75	12	Retinal	retinal	JJ
cord-256217-fnjer0e0	75	13	degeneration	degeneration	NN
cord-256217-fnjer0e0	75	14	in	in	IN
cord-256217-fnjer0e0	75	15	experimental	experimental	JJ
cord-256217-fnjer0e0	75	16	coronavirus	coronavirus	NN
cord-256217-fnjer0e0	75	17	retinopathy	retinopathy	NN
cord-256217-fnjer0e0	75	18	(	(	-LRB-
cord-256217-fnjer0e0	75	19	ECOR	ECOR	NNP
cord-256217-fnjer0e0	75	20	)	)	-RRB-
cord-256217-fnjer0e0	75	21	is	be	VBZ
cord-256217-fnjer0e0	75	22	associated	associate	VBN
cord-256217-fnjer0e0	75	23	with	with	IN
cord-256217-fnjer0e0	75	24	increased	increase	VBN
cord-256217-fnjer0e0	75	25	TNF	TNF	NNP
cord-256217-fnjer0e0	75	26	-	-	HYPH
cord-256217-fnjer0e0	75	27	alpha	alpha	NN
cord-256217-fnjer0e0	75	28	,	,	,
cord-256217-fnjer0e0	75	29	soluble	soluble	JJ
cord-256217-fnjer0e0	75	30	TNFR2	tnfr2	NN
cord-256217-fnjer0e0	75	31	and	and	CC
cord-256217-fnjer0e0	75	32	altered	alter	VBN
cord-256217-fnjer0e0	75	33	TNF	TNF	NNP
cord-256217-fnjer0e0	75	34	-	-	HYPH
cord-256217-fnjer0e0	75	35	alpha	alpha	NN
cord-256217-fnjer0e0	75	36	signaling	signal	VBG
cord-256217-fnjer0e0	75	37	ERS/	ERS/	NNP
cord-256217-fnjer0e0	75	38	ATS	ATS	NNP
cord-256217-fnjer0e0	75	39	task	task	NN
cord-256217-fnjer0e0	75	40	force	force	NN
cord-256217-fnjer0e0	75	41	on	on	IN
cord-256217-fnjer0e0	75	42	undifferentiated	undifferentiated	JJ
cord-256217-fnjer0e0	75	43	forms	form	NNS
cord-256217-fnjer0e0	75	44	of	of	IN
cord-256217-fnjer0e0	75	45	CTD	CTD	NNP
cord-256217-fnjer0e0	75	46	-	-	HYPH
cord-256217-fnjer0e0	75	47	ILD	ILD	NNP
cord-256217-fnjer0e0	75	48	'	'	''
cord-256217-fnjer0e0	75	49	'	'	''
cord-256217-fnjer0e0	75	50	.	.	.
cord-256217-fnjer0e0	76	1	An	an	DT
cord-256217-fnjer0e0	76	2	official	official	JJ
cord-256217-fnjer0e0	76	3	European	european	JJ
cord-256217-fnjer0e0	76	4	respiratory	respiratory	JJ
cord-256217-fnjer0e0	76	5	society	society	NN
cord-256217-fnjer0e0	76	6	/	/	SYM
cord-256217-fnjer0e0	76	7	American	american	JJ
cord-256217-fnjer0e0	76	8	thoracic	thoracic	JJ
cord-256217-fnjer0e0	76	9	society	society	NN
cord-256217-fnjer0e0	76	10	research	research	NN
cord-256217-fnjer0e0	76	11	statement	statement	NN
cord-256217-fnjer0e0	76	12	:	:	:
cord-256217-fnjer0e0	76	13	interstitial	interstitial	JJ
cord-256217-fnjer0e0	76	14	pneumonia	pneumonia	NN
cord-256217-fnjer0e0	76	15	with	with	IN
cord-256217-fnjer0e0	76	16	autoimmune	autoimmune	JJ
cord-256217-fnjer0e0	76	17	features	feature	NNS
cord-256217-fnjer0e0	77	1	Do	do	VBP
cord-256217-fnjer0e0	77	2	corticosteroids	corticosteroid	NNS
cord-256217-fnjer0e0	77	3	have	have	VB
cord-256217-fnjer0e0	77	4	a	a	DT
cord-256217-fnjer0e0	77	5	role	role	NN
cord-256217-fnjer0e0	77	6	in	in	IN
cord-256217-fnjer0e0	77	7	treating	treat	VBG
cord-256217-fnjer0e0	77	8	Ebola	Ebola	NNP
cord-256217-fnjer0e0	77	9	virus	virus	NN
cord-256217-fnjer0e0	77	10	disease	disease	NN
cord-256217-fnjer0e0	77	11	?	?	.
cord-256217-fnjer0e0	78	1	Sci	Sci	NNP
cord-256217-fnjer0e0	78	2	China	China	NNP
cord-256217-fnjer0e0	79	1	On	on	IN
cord-256217-fnjer0e0	79	2	the	the	DT
cord-256217-fnjer0e0	79	3	use	use	NN
cord-256217-fnjer0e0	79	4	of	of	IN
cord-256217-fnjer0e0	79	5	corticosteroids	corticosteroid	NNS
cord-256217-fnjer0e0	79	6	for	for	IN
cord-256217-fnjer0e0	79	7	2019-nCoV	2019-ncov	CD
cord-256217-fnjer0e0	79	8	pneumonia	pneumonia	NN
cord-256217-fnjer0e0	79	9	Herpes	Herpes	NNP
cord-256217-fnjer0e0	79	10	simplex	simplex	NN
cord-256217-fnjer0e0	79	11	virus	virus	NN
cord-256217-fnjer0e0	79	12	encephalitis	encephalitis	RB
cord-256217-fnjer0e0	79	13	update	update	VBP
cord-256217-fnjer0e0	79	14	Diagnosis	diagnosis	NN
cord-256217-fnjer0e0	79	15	and	and	CC
cord-256217-fnjer0e0	79	16	treatment	treatment	NN
cord-256217-fnjer0e0	79	17	of	of	IN
cord-256217-fnjer0e0	79	18	viral	viral	JJ
cord-256217-fnjer0e0	79	19	encephalitis	encephalitis	RB
cord-256217-fnjer0e0	80	1	Exacerbated	exacerbate	VBN
cord-256217-fnjer0e0	80	2	innate	innate	JJ
cord-256217-fnjer0e0	80	3	host	host	NN
cord-256217-fnjer0e0	80	4	response	response	NN
cord-256217-fnjer0e0	80	5	to	to	IN
cord-256217-fnjer0e0	80	6	SARS	SARS	NNP
cord-256217-fnjer0e0	80	7	-	-	HYPH
cord-256217-fnjer0e0	80	8	CoV	CoV	NNP
cord-256217-fnjer0e0	80	9	in	in	IN
cord-256217-fnjer0e0	80	10	aged	aged	JJ
cord-256217-fnjer0e0	80	11	non	non	JJ
cord-256217-fnjer0e0	80	12	-	-	JJ
cord-256217-fnjer0e0	80	13	human	human	JJ
cord-256217-fnjer0e0	80	14	primates	primate	NNS